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The Seven Works of Mercy 
by Caravaggio (circa 1607) 
is in the church of Pio Monte 
della Misericordia in Naples. 
It was created for a charitable 
organisation. The Acts include: to 
bury the dead, visit the imprisoned, 
feed the hungry, shelter the 
homeless, visit the sick, clothe the 
naked and give drink to the thirsty.
(Picture in public domain, 
from Wikipedia)
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This Report describes public health research in European Union countries and the 
role of civil society organisations, particularly the 12 EU new member states. 
It recommends that ministries of health should lead support for public health 
research, and collaborate to develop a European Public Health Research Area.
STEPS (Strengthening Engagement in Public Health Research) was funded by the 
Science in Society programme of the European Commission. It was a collaboration 
from January 2009 to June 2011 between University College London, the European 
Public Health Association, Assocation Skalbes and 12 country partners.  
The report presents results from STEPS. Section one is an analysis of public health 
research in Europe. Section two is a description of national systems for public health 
research. Section three presents the role of civil society organisations. Section four 
makes recommendations. Section five provides more detailed results from the data 
collection. Section six describes the project activities of STEPS.  Section seven 
reprints the paper presented to the EU Consultation on Research and Innovation in 
May 2011.
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0. Summary
Health research and innovation provide the evidence base for health policies and 
practice. Public health draws on research at population and organisational level, 
using statistical, social and behavioural science methods, linking with laboratory 
and clinical medicine, and with wider fields including environment, nutrition and 
economic sciences.
Health is achieved through public health interventions as much as through medical 
treatment. Yet the EU’s current Framework Research Programme allocates just 5% 
of all Health research funding to public health research – the rest is for biomedical 
and biotechnology research. And the EU member states, which provide most of all 
European health research funding, have equivalent patterns. 
STEPS has described public health research systems across all EU member states, 
held workshops between civil society organisations, research organisations and 
ministries of health in the 12 EU new member states (which have the lowest levels 
of research), investigated the use of the Structural Funds for research, and created 
debate on the importance of public health research and innovation for Europe. 
While the EU proposes the value of industry in research and innovation in  
general, public health research needs greater engagement of civil society 
organisations – acting as not-for-profit small and medium sized enterprises (SMEs) 
– for social innovation. 
EU policy is promoting research and innovation forwards to 2020 for economic 
development and to address Grand Challenges for society – including ‘active and 
healthy ageing’.  This requires collaboration towards a European Public Health 
Research Area. 
STEPS recommends leadership by European ministries of health  
in developing public health research:
•  national strategies for research on public health (including health systems and 
services) to meet the major health challenges 
•  a minimum of 25% of all health research funding allocated to public health 
research, both by member states and the European Union
•  coordination between ministries of science, education and finance, including use 
of the national Structural Funds, to develop public health sciences in universities 
and institutes of public health
•  better engagement with public health researchers, users and partners, especially 
through civil society organisations
•  greater coordination and leadership of public health research within the European 
Union research and innovation programmes
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Health is 
achieved through 
public health 
interventions 
as much as 
through medical 
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1. The Setting
1.1  What is public  
health research?
Public health has been defined as “the 
prevention, detection, and control of 
disease, and the protection and promotion of 
health on a community or population level”1. 
Public health research is health research 
at population and organisational level: it 
uses statistical, social and behavioural 
science methods, linking with laboratory 
and clinical medicine, and with wider 
fields including environment, nutrition and 
economic sciences2.
Medicine is practised at both population 
and individual levels, and uses social, 
behavioural and economic sciences as well 
as biomedical laboratory sciences. The word 
‘health’ is also used across these different 
fields, although some distinguish health as a positive state in contrast to disability 
and disease. In this report ‘public health’ is used in distinction to ‘biomedicine’, 
while ‘health’ includes all these fields – as in the title ‘World Health Organisation’ or 
‘ministry of health’.
Thus, ‘public health research’ here includes both research aimed directly at 
prevention of disease (and promotion of health) and also research on systems and 
services for health and healthcare.
‘Health’ is also the term used for the major theme within the European Union’s 
Seventh Framework Programme. It includes public health research, but does not 
include ‘life sciences’ where these are biological studies of other animals and 
plants separately from humans.  Similarly, European and national research councils 
concerned with ‘health’ and ‘medicine’ include public health, but are different from 
both life sciences and social sciences.
1  National Library of Medicine,  
www.nlm.nih.gov/tsd/acquisitions/
cdm/subjects89.html
2  McCarthy M, Clarke A: European 
public health research literatures 
– measuring progress.  European 
Journal of Public Health 2007, 
17(Suppl 1):2-5.
7
STEPS report: Public Health Research – Europe’s Future
Smoking, unhealthy diet, physical activity and 
alcohol cause up to 40% of all premature deaths 
– diseases which could be solved by changes to 
our daily environments and behaviours 
“In both developing and developed regions, alcohol, 
tobacco, high blood pressure, and high cholesterol 
were major causes of disease burden.”1
Studies suggest that in Europe and the USA 
more than half of improvement in avoidable 
mortality in recent decades has been due to 
public health. 
“Clinical services, composed of preventive services 
as well as therapeutic intervention, we credited with 
…half of the 7 or 7½ years of increase since 1950.”2
“Medical care’s contribution to improvements in life 
expectancy in the twentieth century was less than 20%.”3
“Approximately half the decline in U.S. deaths from 
coronary heart disease from 1980 through 2000  
may be attributable to reductions in major risk  
factors and approximately half to evidence-based 
medical therapies.”4
And medical care itself causes iatrogenic deaths 
– estimated up to 100 000 per year in the USA.
“The Institute of Medicine has estimated that  
44,000 to 98,000 deaths occur as the result of 
medical errors.”5
Heart disease has been reduced by public health 
measures in European countries
“Modest reductions in major risk factors [in UK] led to 
gains in life-years 4 times higher than cardiological 
treatments. Effective policies to promote healthy 
diets and physical activity might achieve even 
greater gains.”6
“Use of modern cardiology treatments in Ireland from 
1985 to 2000 gained many thousands of life-years. 
However, twice as many life-years were generated by 
relatively modest reductions in major risk factors.”7
… but in the USA, less than in Europe, because 
of greater increases in obesity.
 “Modest reductions in [USA] levels of smoking, 
cholesterol, blood pressure, and physical inactivity 
… accounted for more than twice as many life-years 
gained as did treatments, but were … partially offset 
by substantial increases in obesity and diabetes.”8
Stroke deaths are much more preventable 
by achievable salt reduction in diets than by 
hypertension treatment.
“A [modest] reduction in salt intake of 3 g per day would 
… be more cost-effective than using medications to 
lower blood pressure in all persons with hypertension.”9
Cancer deaths have mainly been reduced 
through smoking control, not treatment.
“About 146 000 lung cancer deaths were prevented 
or postponed by the decrease in the age-specific lung 
cancer death rates in men between 1991 and 2003.”10
1  Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ. Selected 
major risk factors and global and regional burden of disease. Lancet 
2002; 360: 1347–1360.
2  Bunker JP. The role of medical care in contributing to health 
improvements within societies. International Journal of Epidemiology 
2001; 30: 1260-1263.
3  Mackenbach JP. How important have medical advances been? In 
Sussex J. “Improving population health in industrialised nations.” 
London, Office of Health Economics, 2000 (pp 53-69). 
4  Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in U.S. 
deaths from coronary disease, 1980-2000. New England Journal of 
Medicine 2007; 356: 2388–2398. 
5  Institute of Medicine. To Err is Human: Building a Safer Health System. 
Washington, DC: National Academy of Sciences; 1999.
6  Ünal B, Critchley JA, Fidan F, Capewell S. Life-years gained from 
modern cardiological treatments and population risk factor changes in 
England and Wales, 1981–2000. American Journal of Public Health 
2005; 95(1): 103-108.
7  Kabir Z, Bennett K, Shelley E,  Unal B,  Critchley J,  Feely J, 
Capewell S.  Life-years-gained from population risk factor changes 
and modern cardiology treatments in Ireland. European Journal of  
Public Health 2006; 17(2): 193-198. 
8  Capewell S,  Hayes D,  Ford E,  et al. Life-years gained among US 
adults from modern treatments and changes in the prevalence of 6 
coronary heart disease risk factors between 1980 and 2000.  American 
Journal of Epidemiology 2009; 170: 229-236.
9  Bibbins-Domingo K, Chertow G, Coxson P, et al. Projected effect of 
dietary salt reductions on future cardiovascular disease. New England 
Journal of Medicine 2010; 362: 590-599.
10  Thun MJ, Jemal A. How much of the decrease in cancer death rates 
in the United States is attributable to reductions in tobacco smoking? 
Tobacco Control 2006; 15(5): 345–347.
The benefits of public health research  
(From EUPHA Response to Green Paper Consultation, April 2011)
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The benefits of public health
Major improvements in life expectancy 
and reductions in disability have been 
achieved for the population over the 
last century. Studies (see BOX) in both 
Europe and USA indicate that these 
improvements have been achieved 
at least as much through public health 
measures as through biomedicine. Yet 
despite improving levels of health, illnesses 
remain, and the costs of health care continue 
to rise.  The objectives of public health at 
organisational level include both prevention of 
disease and also more efficient and effective 
health services. 
Public health is an ‘upstream’ activity – and 
public health research is also ‘upstream’: the 
results do not demonstrate immediately as 
health benefits, but are profoundly important in the 
longer term. The interventions in North Karelia, 
Finland, which started in the 1970s, are still 
being analysed for their population health 
impact; the effects of tobacco control – most 
recently regulation in public smoking – are 
demonstrated across decades; and we have 
yet to determine how interventions for healthier 
eating can roll back the contemporary epidemic 
of chronic diseases in Europe and globally. 
Public health research delivers in the long-run through both social and behavioural 
change, often with greater health benefit than treatment, and through management 
of efficient and effective healthcare to maintain a healthy national workforce as 
well as active and healthy ageing. These important messages need to be regularly 
presented to commissioners of health research at national and European levels 
through actions such as STEPS.
Figure 1. Public health 
research publications  
1995-2004 for EU25 
countries
Average annual papers
■ 480-2310 (6)
■ 200-480 (5)
■ 60-200 (4)
■ 0-60 (12)
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1.2 Public health research in Europe
Public health research is undertaken in all EU member states. SPHERE, a study 
undertaken by UCL, EUPHA and other partners in 2005-2007, found that European 
countries produced around 7000 public health research papers a year out of a world 
total of 20,000 (in USA 9000)3. But there are marked differences across Europe in 
rates of publications for academic papers in public health, with a gradient from the 
north and west to the east and south, see Figure 1.
Public health research is a responsibility also of the European Union. In the EU 
Treaties, Article 168 says “Union action, which shall complement national policies, 
shall be directed towards improving public health, preventing physical and mental 
illness and diseases, and obviating sources of danger to physical and mental health”. 
For Research, Article 179 says “The Union shall have the objective of strengthening 
its scientific and technological bases by ... promoting all the research activities 
deemed necessary by virtue of other Chapters of the Treaties”.
The main programme, Cooperation, of the EU’s Seventh Framework Research 
Programme (2007-2013) is divided by themes, of which the first is named Health, 
and is itself divided into three sections: 
•  Biotechnology, generic tools and medical technologies for human health
•  Translating research for human health
•  Optimising the delivery of healthcare to  European citizens
The last of these is health at population and organisational levels – ie public health 
research. The three subthemes are4
•  Clinical research into clinical practice
•  Health systems research
•  Health promotion
(A fourth subtheme, ‘International public health and health systems’, provides EU 
support for health research beyond Europe)
Analysis of the calls for projects in 2007-2012 shows that biomedicine (biology, 
laboratory and clinical) research was allocated almost all the funding, while 
research for public health received only five per cent of the total – at its lowest, just 
€26m out of a total  €658m for 2011 (Figure 2).
It is not possible to make comparison with member state programmes because 
their data are not kept in a consistent, comparable way.
3  Clarke A, Gatineau M, Grimaud 
O, et al. A bibliometric overview of 
public health research in Europe, 
European Journal of Public Health 
2007; 17(Supp 1): 43-49.
4  European Commission, 
Directorate General for Research 
and Innovation, Unit F3. Public 
Health Research in Europe 
and beyond. Luxembourg, 
Publications Office of the 
European Union, 2011.
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Figure 2. EU Seventh 
Framework Research 
Programme: annual 
spending on Health theme 
2007-2012
Years
Spend (€m)
■ Other Health
■ Public Health
700
600
500
400
300
200
100
0
1 2 3 4 5 6
European research policy
The European Union proposes that more spending on research and innovation 
will drive national economic and social development, and improve Europe’s 
global competitiveness. EU policy has therefore been directed towards widening 
the research base, promoting applied research and innovation, and coordinating 
member states actions to achieve a European Research Area. 
The EU meets it responsibilities for research through the Framework Research 
programmes. The current programme (2007-2013) has €6bn of funds for 
competition. Thematic programmes, including ‘Health’, have annual calls in 
specific areas, there is funding for individual researcher-led proposals through the 
European Research Council (established in 2007), and researcher movement is 
supported by Marie Curie scholarships. 
Much more research funding and the research performers, however, come from within 
the EU member states themselves. There are wide differences in levels of research 
funding by the EU member states themselves, ranging from over 4% of gross national 
product (GNP) in some Nordic countries down to 0.5% in some of the EU new 
member states. While research is mostly funded from public budgets, European policy 
is seeking to raise the contributions of industry and business to research. 
11
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Innovation for health in Europe
The European Union strategy for the period 2014-2020 proposes ‘Research and 
Innovation’ as one of seven ‘flagship’ policy areas for coordination and action, and 
achieving 3% of the EU’s GDP allocated to ‘R&D/innovation’ by 2020 is one of five 
headline targets5.  
‘Health’ does not appear directly in the European Union forward strategy to 2020, 
but Grand Challenges of society are recognised. The EU proposes an Innovation 
Union6 as a flagship policy for 2014-2020, and has identified the theme of ‘Active 
and Healthy Ageing’ for a first pilot Innovation Partnership7.  A target of increasing 
life by 2 years for European citizens has been set – which will require evidence-
based public health interventions for its achievement.  Member states approved the 
proposal at the Council of Ministers in March 2011, and the European Commission 
has developed a three-strand programme which is expected to start in 2012.
Two significant social trends support the choice of prioritising Active and Healthy 
Ageing. First, older people, a growing proportion in the European population (people 
are living longer, and lower birth rates mean fewer younger people), must continue to 
be economically active to maintain their living standards and to balance the transfer 
costs from others in society.  Second the costs of health systems, with increasing call 
for long-term treatment and care for chronic diseases, must also be balanced. The 
epidemic of obesity, for example, threatens living standards as it both diminishes the 
working life-span and creates long-term medical expenditures.
The Innovation Partnership for Active and Health Ageing provides a broader 
framework for health within the European Union’s 2014-2020 strategy. Life-course 
research shows that health and ill-health develop continuously from the start of 
life, not just in older age, so that interventions must be for the whole population. 
The challenge, however, is how the EU and member states will collaborate on the 
Innovation Partnership programme, as it as yet has no identified separate funding. 
At present the programme developed by the European Commission’s Health 
Directorate focuses on health technology assessment and information technology, 
areas with strong industry involvement.  Further attention needs to be given to 
structural issues of maintaining economic and social activity through public health 
protection, and improving the deployment and activities of staff that determine the 
efficiency and effectiveness of health care systems.
5  European Commission. Europe 
2020: http://ec.europa.eu/
europe2020/targets/eu-targets/
index_en.htm
6  European Commission. Europe 
2020: Flagship Initiative, 
Innovation Union. COM(2010) 
546 final
7  Pilot European Innovation 
Partnership on Active and Health 
Ageing. http://ec.europa.eu/
research/innovation-union/
index_en.cfm?section=active-
healthy-ageing
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2.  Systems 
for health 
research
A health research system has been 
defined as “the people, institutions, and 
activities whose primary purpose in relation 
to research is to generate high-quality 
knowledge that can be used to promote, 
restore, and/or maintain the health status of 
populations”8.  European governments and 
the European Union attended the Global 
Forum for Health Research Ministerial 
Conference in Mali in 2008. In May 2010, 
EU countries contributed to approving the 
WHO Research for Health Strategy of the 
63rd Regional Health Assembly through 
their ministries of health9. The World Health 
Organisation will publish its annual Report 
in 2012 will be on the theme Research for 
Health, and provide ‘pragmatic advice for member states on how to strengthen 
their own health research systems’. 
2.1 National research systems
Health research engages broadly across disciplines, practitioners and policies. 
Public health research includes health policy and systems, epidemiology and 
health promotion, and health care services including organisational and technology 
assessment. Clinical research concerns the identification and better management 
of diseases, including clinical trials. Laboratory research looks at disease at 
cellular, genetic and molecular levels, and crosses into other life sciences. 
National research systems are usually led by Ministries of Science, with advisory 
councils of researchers. Typically these latter are discipline-led, and biomedicine 
holds an important place in the ‘health’ research agenda.  Sometimes the advisory 
council is termed ‘medical’, and may ignore public health research.  
Governments have sought to achieve a balance between basic and applied 
research, an issue which continues in comparing research and innovation. Yet 
research systems are asymmetrical. Ministries of science hold the main funding for 
research, but the findings from science are often applied within the fields of other 
ministries. Ministries of health have to respond to changing medical knowledge and 
technologies both because these can improve health for the population and also 
because they may create cost pressures on health care systems.
8  Pang T, Sadana R, Hanney 
S, Bhutta ZA, Hyder AA, et al. 
Knowledge for better health - A 
conceptual framework and 
foundation for health research 
systems. Bulletin of the World 
Health Organisation 2003, 
81:815–820.
9  World Health Organisation: 
Research for health strategy  
www.who.int/rpc/research_
strategy/en/index.html
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STEPS sought to describe the systems for public health research across the 27 
EU member states. Although the European Commission tracks the overall research 
systems in these countries through ERA-Watch, there has been no detailed 
attention to public health research.  STEPS created an organogram of public health 
research in each country, based on the flow of resources (Figure 3). 
Important issues that emerged were:
•  Almost all member states have strategies for research, which often identify 
health. (For example, France’s National Research and Innovation Strategy has 
three priorities, of which the first is ‘Health care, nutrition and biotechnology’.) 
But  fewer countries have strategies specifically for health research, and rarely 
are there research and innovation strategies that lead from the priorities of the 
national health plans. An important reason for these weaknesses is that science 
ministries mainly draw on life and biomedical scientists for their advisory 
councils. Ministries of health and public health researchers are rarely involved 
in the development of research programmes or the decisions on which science 
to fund. 
•  Public health research is not sufficiently recognised within the national 
structures. In several countries, particularly in the new member states, there 
is a ‘national’ public health institute that is fully or partly funded by the ministry 
of health. But this institute may have a range of practical tasks, for example 
in analytic laboratories, surveillance and reporting, and insufficient funding 
of research infrastructures. By contrast, there is much less recognition by 
ministries of science to support research in the departments of universities that 
can draw on both social and medical sciences within their faculties, and address 
the contemporary health problems in new ways.  
Research Commissioners
Ministry of 
Science
Ministry of 
Health
Other
ministries Regions Foundations
Mixed organizations
Universities State Institutes Health services Independent organizations
Research Performers
Figure 3. Template 
organogram for public 
health research systems in 
EU member states
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•  In the larger EU countries, there can be several sources of funding beyond the 
ministry of science. Sweden, for example, draws health research funding from 
regional authorities, independent foundations and disease-specific charities, 
while in Germany the health insurance organisations also contribute.  But 
there is insufficient coordination and only a small proportion of their budgets is 
directed to public health research.
•  There is no coordination of health strategies between countries, and the link to 
European priorities is unclear.  More than 20 organisations responded to the 
European Commission’s consultation for the next framework research programme 
from a public health perspective, and some countries have put forward proposals 
for health research priorities. But the mechanism for dialogue with the EU health 
research programme is not transparent and there are few ways – beyond Joint 
Programming – that member states share health research agendas. As a result, 
there is inconsistency and duplication between member states.
Research strategies
STEPS identified national research strategies in 25 of 27 EU member states (and 
strategic statement in two). Seventeen explicitly referred to health and ten to public 
health research themes (Table). Some research (and innovation) strategies were 
formulated not thematically but according to capacity building, for example, human 
resources, structures and team building. In some countries, strategy is led by the 
governmental research agency rather than direct national research strategy. In 
Belgium research is not led at national level but at the Communities level. There 
were nine national or research agency strategies directly for health or public health 
research. Research is also discussed within some national health strategies, and 
public-health strategies. For example, Finland has a public health programme 
“Health 2015” that includes sections on public health research, including health 
promotion, health policy research and social epidemiology, while the UK has a health 
research strategy and also a named public health research programme. 
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Table. Research strategies 
or statements of research 
priorities identified by 
STEPS in 2010
Y = Yes (strategy or *mention identified) 
Country
National research strategy / 
priorities 
National  health 
research strategy
Strategy 
referring to 
health
Strategy 
referring 
to public 
health 
research
Strategy
Strategy 
referring 
to public 
health 
research
Govern-
mental
health 
research 
agency 
strategy
Strategy
 Austria Y     
 Belgium Y     
 Bulgaria Y     
 Cyprus Y   
 Czech Rep. Y Y Y Y Y 
 Denmark Y Y Y   Y
 Estonia Y     
 Finland Y Y    
 France Y     Y
 Germany Y Y  Y Y 
 Greece Y Y    
 Hungary Y     
 Ireland Y Y Y Y Y Y
 Italy Y Y  Y  
 Latvia Y Y Y   
 Lithuania Y     
 Luxembourg Y     
 Malta Y     
 Netherlands Y Y Y  Y Y
 Poland Y Y Y   
 Portugal Y     
 Romania Y Y    
 Slovakia Y Y Y   
 Slovenia Y Y    
 Spain Y Y Y   
 Sweden Y Y Y   Y
 UK Y Y Y Y Y Y
16
STEPS report: Public Health Research – Europe’s Future
Research commissioners 
Organisations at commissioning level holding the budgets that fund public health 
research are ministries, national agencies and devolved (e.g. regional) organisations, 
and private not-for-profit organizations (“foundations”).  Most countries have a 
ministry with responsibility for science.  Some countries have adopted the word 
‘innovation’ within the ministry’s title.  Some countries manage their science portfolios 
(and indeed formal representation at European level, for example in the European 
Science Foundations) through the business or economic ministry.  
Ministries of science usually hold and allocate funds for science themselves, but 
in some countries allocations pass directly from the ministry of finance to research 
commissioning bodies, which may be independent or directly linked to government 
or parliament. Ministries of health, either alone or in association with ministries of 
science, also fund health research agencies, or agencies that fund and perform 
research. Research relevant to public health is also funded through government in 
other policy areas such as transport, food, information technology, employment and 
environment. These ministries may recognise health protection as an outcome of 
their policies or because scientists within their policy area also link up to medical and 
health issues. 
Independent funding varies more by country. In some European countries, funds 
for specific diseases raised directly from the public are used for research. Another 
model is of not-for-profit foundations set up by industry. Typically, these independent 
sources of finance have been directed more towards biomedicine than public health 
research, although there are smaller independent foundations with areas of concern, 
such as for AIDS, or health systems research, or environmental concerns, where 
public health is significant partner.
Research performers
At present, there is no European listing of university departments undertaking 
public health research.  This is a significant lack, since the universities are the main 
avenues for development of the medical, social and economic sciences relevant to 
interdisciplinary public health research, and also the main receivers of public funds 
for research grants and infrastructures. Future work with the European Universities 
Association, which has around 850 member institutions, could develop this listing.  
While in some countries the ministry of health directly funds a single national school 
of public health, in most other countries public health teaching and research has 
extended regionally within universities, many of which have gained equivalence 
with the national school. There are also independent health research organizations, 
including fully private, private with some degrees of public funding, non-governmental 
organisations, and civil society organisations.
17
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State institutes are generally funded by a ministry. The most visible national 
organizations undertaking public health research are national institutes primarily 
concerned with infectious disease and environmental control and health surveillance. 
Some institutes have broadened their roles to include chronic disease control, 
epidemiology and health behaviours. Institutes usually decide their own research 
agenda through funds agreed with their ministry.  Institutes with health interest 
within other disciplines include environmental protection and occupational disease; 
food safety; and health services management, health economics and health 
technology. Most of these organizations are state institutes, but some are gained 
independent statutes.  
In several European countries there are ‘mixed organisations’ which both allocate 
funds, sometimes with internal and competitive research, and also perform research. 
This structure also predominates for the Academies of Science in most of the former 
communist countries.   Mixed organisations are frequently multi-site, sometimes 
“research chains” which set the priorities for research in discussion with the ministry 
of science. In academies in the eastern EU member states, the autonomy is greater, 
although there have been mergers as limited funds are moved towards universities.
Programmes and calls
Some research performers are funded directly through regular negotiation with their 
commissioners - generally ministries. This generally applies to institutes of public 
health and in specialised fields such as environmental health. However, research 
is increasingly funded in response to competitive calls. Programmes and calls may 
be i) thematic, focused on a defined subject area; ii) general, such as to reinforce 
research capacity (scholarships, seminars, training, grants for visiting researchers); 
iii) open to any subject, with funding dependent on the quality of the proposal. 
It proved impossible to describe public health programmes and calls systematically 
because of the diversity of funding streams and organisations, as indicated above, 
and the lack of separation of public health from other related research – biomedical, 
clinical or wider determinants of health. Uniquely in France, a specific organisation, 
Groupement d’Intérêt Scientifique - Institut de Recherche en Santé Publique 
(GIS-IReSP) has been established which has identified public health research 
funding from 28 sources as well as commissioning some research directly.  In other 
countries, health research programmes and calls can be found through web pages of 
the ministries and organisations listed in Appendix.
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2.2  Research and the Structural Funds in the EU 12  
new member states
The European Union’s budget, comprising just over 1% of total GNP of the member 
states, is allocated in two major tranches – 43% for natural resources (mainly the 
common agricultural policy), and37% for cohesion policy. (The budget for research, 
education and training is around 7% of the total, and for the Health Directorate only 
0.07%.) In the period 2007-2013, the EU has allocated most of these funds to the 
84 regions in 17 Member States that have per capita GDP less than 75 % of the 
Community average.  
There are three funds for Cohesion Policy 
•  Regional Funds (ERDF) – “helping regions to anticipate and promote economic 
change through innovation and the promotion of the knowledge society”.
•  Cohesion Funds (CF) – for Member States and regions whose GNP is lower than 
90% of the EU average
•  Social Funds (ESF) – “strengthening competitiveness and employment by… 
investment in human resources, the development of qualifications and competences, 
[and] the dissemination of information and communication technologies”.
How much funding? How is it used?
The Structural Funds are spent on programmes devised and implemented by the 
member states, not centrally by the European Commission. However, country 
programmes are agreed with the Commission, and follow EU policies. Over the full 
period 2007-2013, around €86 billion, almost 25% of the total, about the funding 
was directed to research and innovation10.  Of this, €50 billion is for “R&D and 
innovation in the narrow sense” – including €10billion infrastructure, €9 billion 
for investment in firms, €6 billion each for R&TD research centres, assistance to 
SMEs, and improvement of networks, €5 billion in developing human potential, and 
€3 billion for  SMEs environmentally-friendly products and processes. 
Little information published by the Commission on the actual use of the Structural 
Funds in the current programme, except gross expenditures. On the web page for 
Cohesion Policy, there is a drop-down menu for Projects. When choosing Research, 
Innovation and Technological Development, the 12 EU countries have together 46 
projects listed, but they are all large, engineering, technology or science parks. There 
appears no way to interrogate the system for ‘specific projects in Human Health’.
A request for information to the European Commission received the following reply:  
“Concerning the rate of implementation of this €86 billion, the latest available figures 
(Annual Implementation Reports 2009, provided by the Member States in July 2010) 
show that about €30 billion have been allocated to specific projects (out of which 
€16 billion for R&D&I in a narrow sense, see webpage). The remaining part will be 
committed before the end of 2013. Moreover, about 3% of the €30 billion (and 5 
% of the €16 billion) have been allocated to specific projects in the area of Human 
Health.”11 (It is unclear the Commission refers here to health research projects, or to 
other programmes and projects more broadly for healthcare12.)
10  European Commission. Staff 
Working Document. Regions 
delivering innovation through 
cohesion policy. Brussels, 
14.11.2007 Sec(2007) 1547
11  Email correspondence from 
European Commission 
Directorate for Regions
12  European Commission. 
Inforegio. http://ec.europa.eu/
regional_policy/themes/research/
index_en.htm
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Use for health research in new member states
STEPS undertook an analysis of national web pages to identify the use of 
Structural Funds for health research in the 12 EU new member states.  Findings by 
country are given in Chapter 7, and summarised here. 
The majority of these 12 countries had R&D levels well below the EU average 
at the beginning of the period, at 0.6% of GNP or less.  Two countries, Czech 
Republic and Slovenia, however, were 1.6%, closer to the EU’s average level of 
1.9%, with Hungary, Estonia, and Lithuania between 1% and 0.8%.
The overall allocation of the Structural Funds is strongly influenced by the 
population size of the country – Poland receives a quarter of the total, while 
small countries gain much less. However, the information available from the 
larger countries is less satisfactory than in some smaller countries, and the other 
countries provide important examples of alternative approaches.
Some countries, eg Estonia, Latvia, Lithuania and Slovakia, stand out in using 
the Structural Funds actively for research, and a few have developed competitive 
research calls from their funds. Some countries have put funding primarily into 
‘centres’, eg Slovenia. And in some countries, for example Malta and Slovakia, 
there is evident use of the ESF human resources funds to promote research 
capacities, with masters, doctorate and post-doctorate programmes. Bulgaria, by 
contrast, has apparently no direct investment for research, although innovation 
could be supported in “R&D institutions and organizations, municipalities, private or 
public bodies including NGOs”.
The funds are administered in very different ways. A minority of countries use their 
existing research management institutions – for example, Cyprus placed its Structural 
Funds for research into the governmental research agency. Malta placed €20m for 
a molecular genetics centre within an agency working under the Ministry of Finance. 
Mostly, however, it was not clear which organization is managing the funding.  While 
in the main the allocations were not identified to academic fields, in a few countries 
there were developments of biomedical centres with capital costs – for example, Czech 
Republic proposes a molecular biology centre outside Prague of €100m.  Only in one 
country, Lithuania, was there evidence of research for public health research, under the 
title ‘administrative capacity and efficient public administration’.
In summary, while the data were poor, especially in comparison with information 
about  the Seventh Framework Research Programme, it appears that neither public 
health research nor social research are prioritised in the Structural Funds for research 
programmes, infrastructures or ‘centres’, which are predominantly engineering and 
technical. Yet public health research would be able to compete if calls are developed 
appropriately, and also in support for researchers and buildings - Lithuania appears to 
be a strong example. Much more information is needed to determine if European funds 
are being used effectively in support of European health policy. 
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3.  Partners 
for health 
research  
STEPS was designed to give special 
attention to the contributions of civil  
society organisations for health research - 
which include national associations  
for public health.
3.1 Civil society organisations
The EU Science-in-Society programme call 
that generated STEPS13 proposed research 
on civil society organisations. Science-in-
Society has traditionally been concerned 
with the perspective of scientists, including 
the ethical base for research, provision for 
exhibitions and communication with the 
public. The call for capacity-building in civil 
society organisations raised the possibility of moving the debate from how the 
public can be better informed about research, to how the public can contribute to 
determining needs and agendas for research.  
The 1998 UN Aarhus Convention affirmed the access of civil society to information 
and to participation in international debate, particularly on the environment.  In 
2001, the European Commission’s White Paper on Governance stated the policy 
for open consultation with all ‘interested parties’, and that all fields of European 
Commission work should include contact with civil society.  At European level, the 
European Commission’s Directorate for Health and Consumers Health has been 
leading in this development, with the European Health Policy Forum bringing civil 
society organisations together to meet the European Commission twice annually, 
as well as a larger annual meeting open to individuals.  
What are civil society organisations?
Civil society organisations, in the definition of the European Commission, are 
‘not-for-profit non-governmental organisations operating in the public interest’14.  
From a health perspective, categories of civil society organizations include 
organizations which promote specific health-related purposes (such as information, 
advocacy or policy-shaping), organizations aimed at self-support and protecting 
the rights of patients and vulnerable groups, organisations providing services, and 
organizations supporting the professions in their practice  or employees’ interests 
in their relation to their employers.
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13  EU Seventh Framework 
Research Programme. SiS-2007-
1.2.1.1 – CSO capacity building 
in research
14  European Commission and Civil 
Society (2010). http://ec.europa.
eu/civil_society/apgen_en.htm 
(accessed 7 April 2011)
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Civil society contributions to public policy developed in the 1970s in the 
environmental field. In health, not-for-profit organisations have provided 
services for many years, for example the Red Cross, religious organisations, 
for children and for people with disabilities. HIV/AIDS from the 1980s brought 
a new urgency for collaboration between decision-makers and civil society, for 
appropriate services and to change public behaviour. From the 1990s, civil society 
organisations have also been encouraged in Eastern European countries through, 
for example, the Open Society Institute. 
Engagement of civil society in health research is also an objective of the World 
Health Organisation. The Council for Health Research and Development, 
supporting the development of health research in low and middle income countries, 
has promoted engagement with civil society organisations with governments, 
academia, funding agencies and technology councils.  Ministers of Health, at the 
Global Forum for Health Research meeting in Mali in 2008, called for civil society 
and community participation ‘in the entire research process, from priority setting to 
the implementation and evaluation of policies, programmes, and interventions’. 
Academic studies have described the contribution of civil society organisations to 
health research in low and middle income countries, but there has been less attention 
given to this field in Europe. SPHERE, a descriptive study of public health research 
in Europe, recorded priorities for research from the perspective of national public 
health professional associations15 and at a meeting in Bratislava, Slovakia, in 2008, 
CSOs from Eastern European countries discussed their interests for activism, health 
promotion, and delivery of health services through the voluntary sector. STEPS sought 
to build on these initiatives with a special focus on civil society organisations in the 
twelve member states that joined the European Union in 2004 and 2007. 
STEPS surveys
To assess the perspectives of civil society organisations and health research, 
STEPS partners undertook two surveys – the first drew 128 responses from 
civil society organisations in 8 new member states, the second investigated the 
perspectives of 13 health CSOs operating at European level. 
The surveys showed that civil society organisations have an interest and 
experience in research related to public health, or more generally in the social field; 
and that they seek continued and greater engagement.  The majority of CSOs were 
themselves not involved directly in research, both for lack of knowledge and human 
resources, although a minority described contributing to research particularly 
collecting information on needs and services. But they were interested in working 
with research organisations and institutes, so to raise the quality of the research 
from the perspective of both sides. 
15  Gulis G, Garrido-Herrero L, 
Katreniakova Z, Harvey G, 
McCarthy M. Public health 
research priorities in Europe 
seen by non-governmental 
organizations.   Central 
European Journal of Public 
Health 2008;16(4):209-12.  
AND  McCarthy M, Harvey G, 
Conceição C, La Torre G, Gulis 
G. Comparing public-health 
research priorities in Europe. 
Health Research Policy & 
Systems 2009; 7: 17.
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In contrast to commercial research, which seeks to develop patents and control 
knowledge from research, civil society organisations are interested in wide 
dissemination of knowledge and its use across society. There was a desire for 
greater communication and dissemination about research, both the results from 
completed research and earlier involvement on forthcoming projects. Better 
methods for dissemination need to be developed, using networks and electronic 
communication, at national level using national languages and also European-wide. 
A further dimension is defining the field of action for public health. Many countries 
have held major political debates on the structures, provision and financing of 
health care (especially hospital care), but these have not been supported by 
scientific technical discussion nor a view of the broader objectives of a health 
system in controlling disease and promoting health. Equally, several countries 
have not yet made the transformation from public health through control of 
communicable diseases to a modern public health system concerned with action 
on the determinants of health, including social behaviours, urban environments, 
housing, inequalities, and issues related to human rights.  While CSOs can usually 
identify the main actors within the public health system, they feel less able to 
decide which organizations are suitable for partnership in health research policy, 
development and implementation. 
3.2 CSOs, SMEs and social innovation
EU policies (and some member states) emphasise research and innovation by 
the private sector (industry) to create economic growth.  Industry leads in some 
traditional economic sectors such as manufacturing, agriculture and transport. But 
Europe’s economy is more than 60% in services, and the healthcare sector – almost 
10% of the total European economy – provides mostly services that are not-for-profit. 
Similarly, EU policy encourages the development of small and medium enterprises 
(SMEs) in the private sector, including in health field16. Yet not-for-profit civil society 
organisations are also legally SMEs: they are ‘entrepreneurial organisations’ with 
financial basis and employing fewer than 250 staff. And CSOs have a relation 
to research and innovation which is very similar to those of industry SMEs. 
While neither usually have research as a primary interest, they wish to use the 
results from research, and may initiate or work with researchers and research 
organisations to improve services, improve efficiency or meet new needs. And 
research commissioning organisations are realising the importance of CSOs in the 
formulation of research relevant to the health sector, and in working through them 
for better engagement with citizens or patients. 
16  Formerly SMEs-Go-Health, now 
a new programme Fit for Health, 
http://www.fitforhealth.eu/
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In a speech during the consultation of the Innovation Union, EU Commissioner for 
Research Marie Geoghan-Quinn said (Brussels, 17 May 2011):‘Yes, social innovation 
can help us to meet new and unmet needs in society… That, in the end, is what the 
Innovation Union is all about.’ She continued: [We] ‘will set up a Social Platform … 
drawing up a European research agenda focusing on health, welfare and education 
services.’ For health, civil society organisations can provide a balance to the strong 
influence of industry in orienting medicine towards treatment rather than prevention, 
and for-profit rather than socially-oriented interventions. The contribution of CSOs 
to research in areas of health policy such as tobacco and alcohol, AIDS and social 
care has already been highly significant. In the new field of ‘social innovation’, CSOs 
operating as SMEs will increasingly, provide the ‘European social model’. 
3.3 European representation
No organisation represents all health research for Europe. 
•  The European Medical Research Councils (EMRC), part of the European Science 
Foundation sited in Strasbourg, France, brings together both research commissioning 
and research performing organisations and assists thematic collaboration between 
30 countries. However, EMRC focus is on biomedicine: it does not address social 
sciences, and has little engagement with ministries of health. 
•  The international offices of member state ministries of health do not usually take 
a direct interest in health research. Every EU member state has a Permanent 
Representation in Brussels; but representation for research is usually separate 
from the representation for health, and the national policy officers meet together 
in two different informal committees on different days. 
•  Equally, in the European Parliament,  health and research are separate, and 
linked to other policy fields as the Committee for Environment, Public Health and 
Food Safety, and the Committee for Industry, Research and Energy. 
The European Commission’s web pages about research (ERAWATCH) and innovation 
(Pro-Inno) in member states describe generic structures, and do not necessarily include 
research support by external ministries such as the ministry of health.  The European 
Commission has appointed nationals for direct links with member states: the Directorate 
for Health has National Contact Points, usually but not necessarily sited within the 
ministry of health; and the Directorate for Research has National Focal Points, usually 
but not necessarily in the main research commissioning organisation, and (depending 
on the country size) subdivided into themes (sometimes including health). 
Nevertheless, the prime concern of these contacts is to distribute information 
downwards about European Commission activities relevant to member states, 
particularly funding programmes. Information passes upwards from countries to the 
European Commission formally through advisory committees, but the work of these 
groups is unclear as it is rarely in the public domain. 
There is no systematic engagement of the research advisory process with either 
public health associations or with civil society organisations. This leads to lack of 
prioritisation for public health on national and European research agendas.
There is no 
systematic 
engagement 
of the 
research 
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process 
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public health 
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4.  The Way 
Forward
4.1  Partnership and 
engagement for health 
research
The structure of advice on health research 
within the European Commission Directorate 
for Research and Innovation is not fully 
transparent. A Health Research Advisory 
Committee, with member state representation, 
meets twice yearly to review the annual 
programme. The Committee’s chair is 
currently also the Chair of the European 
Medical Research Councils, a sub-committee 
of the European Science Foundation which 
represents biomedicine more than public 
health. It does not appear that ministries of 
health are directly represented. 
The European Union’s Seventh Framework Research Programme 2007-2013 
allocates funding under four main headings: Cooperation across Europe on 
thematic calls; Ideas submitted to the European Research Council; People and 
mobility through the Marie Curie funds; and Capacities including other smaller 
actions. (Other funding goes to the Euroatom and the Joint Research Centre.) 
Health research is estimated to receive around 15% of the total funding, around 
€1bn per year.  This is twenty times more than the €55 million allocated annually 
to the European Commission’s Directorate for Health and Consumers, but 20 
times less than the $30 billion that US Congress allocates annually to its National 
Institutes of Health. Further EU funding for Research and Innovation is available 
through the Structural Funds. 
The next Framework Research Programme – ‘Horizon 2020’
The European Commission consultation on funding for research and innovation 
in the first half of 2011 received more than 800 responses17.  In its forward budget 
for 2014-202018 (yet to be agreed by Parliament and the Member States), the 
Commission recommends a 50% increase for Research and Innovation, up to 
€11.5 billion annually. Support for ‘R&D’ will continue within the Structural Funds 
(now termed ‘Cohesion Instruments’), although no figure is given.  The budgets 
within the Directorate for Health and Consumers are essentially unchanged, 
although the Directorate may receive a further €310m a year for animal and plant 
safety, transferred from the Agriculture directorate. 
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17  European Commission Research 
and Innovation. “Horizon 2020” is 
the new name for the future EU 
funding programme for research 
and innovation.  
http://ec.europa.eu/research/csfri/
index_en.cfm?pg=younameit
18  European Commission. A budget 
for Europe 2020. Part 2: policy 
fiches. COM(2011) 500 final,  
29 June 2011.
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In July 2011, the European Commission Directorate for Research and Innovation 
held a two-day meeting between its Health Research Advisory Committee, inviting 
150 researchers and research managers to consider the next programme. Nine 
themes were discussed in open sessions. Links were recommended with other 
disciplines, such as environment and nutrition, and fields, such as mathematics 
and modelling. There is a strong need for Europe-wide databases, both to link 
surveillance and longitudinal studies across EU countries, and to draw observational 
data from clinical records rather than cumbersome randomised trials. The value of 
biomarkers and new diagnostics needs to be scrutinised, and there was frustration 
that the term ‘personalised medicine’ is raising expectations which cannot be met 
by pharmaceuticals (‘homogenous groups’ might be possible).  Gaps in research 
include the contribution of behavioural and policy research, not only for national 
health objectives but also in implementation in fields such as IT, infection control, 
patient perspectives and clinical guidelines. Many spoke on the need for more holistic 
research on prevention, and public policy to extend lives and reduce morbidity. 
Innovation Partnership
To meet the agenda of Active and Healthy Ageing Innovation Partnership, there 
must be better cooperation with social sciences in commissioning and projects, 
and greater involvement and funding from ministries of health.  Wider concerns 
include the need to engage with patients and civil society organisations, and 
support infrastructures and training programmes. Links need to be transparent 
between the Research and Innovation Directorate and the Directorate for Health 
and Consumers, and also with other European Commission directorates with 
policy areas impacting on health, including environment, transport, food, regional 
planning and economy.  Perhaps the most critical issue for health will be whether 
research and innovation for Active and Healthy Ageing will be directed by current 
EU advice towards markets, industry and the for-profit economy, or on needs for 
social innovation towards broader, more holistic objectives for Europe’s citizens19. 
European Public Health Research Area
All European member states can contribute to creating the evidence-base to 
achieve the Innovation Partnership target of adding 2 years of life for all citizens 
by 2020.  The research and innovation will need to join with clinical and social 
sciences, and will need to focus on social and behavioural interventions in public 
policy, including at local levels, and organisational interventions to improve 
effectiveness and efficiency within health services.  A research ‘market’ – a 
European Public Health Research Area – will encourage both competition, 
development and implementation of research, maximising the benefit of the 
‘investment’ by both science and health ministries. 
19  McCarthy M. Health research 
– Europe’s future. The Lancet 
2011;377:1744-5.
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4.2 Recommendations
STEPS has sought to promote awareness of public health research with civil 
society and other stakeholders in the new member states, with ministries of health 
across the EU, and with researchers and the European Commission through 
EUPHA’s annual conferences. It has engaged with the development of research 
and health policy for both the EU and its member states for the forthcoming period 
in Europe. It has also produced academic papers putting knowledge of these 
issues in the science literature.
Public health research addresses health at population and organisational level, 
complementary to biomedical research at individual and laboratory levels. 
As a Support Action for Science in Society, STEPS recommends change and 
development for public health research in Europe. This will take up the challenges 
set by the Global Forum for Health Research and the World Health Assembly to 
promote research broadly for health, rather than just for biomedicine and to include 
2% of health systems funds for health research.
STEPS recommends leadership by European ministries of health in 
developing public health research:
There should be 
•  national strategies for research on public health (including health systems and 
services) to meet the major health challenges 
Most member states have national health strategies aimed at the major health 
challenges, both acute and chronic diseases, through behavioural, social and 
environmental determinants of health, and in the development, organisation, 
and funding of health systems. Yet only a minority of EU countries with health 
research strategies, and fewer with research strategies directed to public health 
(including health systems and services). Public health policy needs a secure 
evidence base for effective interventions, gained through a strategic approach 
to public health research. 
•  a minimum of 25% of all health research funding should be allocated to public 
health research, both by  member states and the European Union 
STEPS found that only 5% of EU funds for health research currently are directed 
to public health research, and there are no adequate data for member states.  
This contrasts bleakly with the evidence that the benefits of public health are at 
least equal to those of biomedicine.  The global meeting of ministers of health 
in Mali in 2008 urged governments to allocate at least 2% of the health service 
budgets of ministries of health to research20.  In EU member states, funding for 
research can come from healthcare funders, including ministries of health, as 
well as from ministries of science. Along with the European Union’s programme 
Horizon 2020 and the Structural Funds, a minimum level of 25% of all health 
research funding should go to broad public health research.  
20  World Health Organisation.  
http://www.who.int/rpc/whr2012/
en/index.html
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•  coordination between ministries of science, education and finance, including 
use of the national Structural Funds, to develop public health sciences in 
universities and institutes of public health 
Collaboration between ministries of health and ministries of science is weak in 
many EU member states, and the different responsibilities are not necessarily 
clear. Beyond ministry of health support for a national institute of public health, 
expansion of multi-disciplinary research in universities is needed, drawing from 
an increasingly wide range of academic disciplines, and Schools of Medicine 
need to teach public health within medicine as well as undertaking broad 
socio-medical research. The research strategies of ministries of health should 
integrate with ministries of science in the promotion of public health research. 
•  better engagement with public health researchers, users and partners, 
especially through civil society organisations 
STEPS found that civil society organisations are capable and interested in 
support health research. CSOs can link with research across service fields 
including mental health, HIV-AIDS and disability, across behaviours including 
action on smoking, alcohol, diet and exercise, and in health service provision 
including patient-perspectives, social services and integrated care.  Many CSOs 
are legally ‘small and medium enterprises’ (SMEs).  EU policies should give 
CSOs the same opportunities for engagement with research – in not-for-profit, 
’market failure’ areas – as are given to industry. There can also be greater 
engagement between civil society organisations and public health researchers 
in developing research and the wider dissemination of knowledge. European 
mechanisms exist, including Era-Nets and Joint Programming, and through 
organisations such as the European Public Health Association and European 
Science Foundation.
•  greater collaboration and leadership of public health research across the 
European Union research and innovation programmes 
Public health research, including health systems and services research, has been 
the weakest pillar within the Health theme of the Seventh Framework Research 
Programme. There should be full recognition of public health research across all its 
dimensions. Allied disciplines of research include epidemiology, systems modelling, 
health economics, health services research and health management sciences; and 
related research in nutrition, environment, transport, trade and economy for Health 
in all Policies.  There must also be support for public health research within the 
Marie Curie (human mobility) programme, European Research Council (individual 
researchers), and major infrastructures support programmes.  
STEPS recommends attention to these proposals by European member state 
ministries of health and of science, European Institutions, and organisations and 
individuals from research, professions and civil society. 
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5.  Support 
materials 
Full STEPS materials are on the project web 
pages at www.steps-ph.eu 
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5.1  Public health research structures in EU member states
Austria
Belgium
Bulgaria
Cyprus
Czech Republic
Denmark
Estonia
•  Federal Ministry of 
Health
•  Federal Public 
Health Service 
•  Ministry of Health
 
•  Ministry of Health
 
•  Ministry of Health 
Internal Grant 
Agency
•  Danish National 
Board of Health
•  Danish Centre for 
Health Technology 
Assessment
•  National 
Cooperation Forum 
on Health Research
•  Ministry of Social 
Affairs 
•  The Austrian 
Science Fund 
•  Austrian Research 
Promotion Agency
•  Fonds de la 
Recherche 
Scientifique, 
•  Fonds voor 
Wetenschappelijk 
Onderzoek – 
Vlaanderen
•  Ministry of 
Education, Youth 
and Science
•  The Cyprus 
Research Promotion 
Foundation 
•  Ministry of 
Education, Youth 
and Sports (MEYS 
CR) 
•  Grant Agency of CR 
(Public Health Care, 
Social Medicine)
•  Technological 
Agency of CR
•  Danish Council 
for Independent 
Research - Medical 
Sciences 
•  Danish Council for 
Strategic Research - 
thematic calls.
•  Five Danish Regions 
•  Research and 
Development 
Council 
•  Estonian Science 
Foundation 
•  Archimedes 
Foundation
•  The Ludwig 
Boltzmann Society 
LBG 
•  Nine Austrian 
provinces
•  Ludwig Bolzman Institutes: health 
promotion; social psychiatry; health 
Technology assessment. 
•  Health Austria GmbH, Federal Institute 
for Health Care, Healthy Austria and 
the Federal Institute for Quality Health 
(funded by the Federal Minister of Health) 
•  Belgian Health Care Knowledge Centre
 
•  National Centre of Public Health and 
Analyses
•  Bulgarian Academy of Sciences 
(Biomedicine and Quality of Life)
•  Department of Social Medicine and 
Health Care Management, Medical 
University, Sofia
•  University of Nicosia 
•  National Institute of Public Health
•  Academy of Sciences of the Czech 
Republic
•  Public universities 
•  Departments of Social medicine & public 
health care, in Prague, Hradec Králové 
and Pilsen, Brno, Olomouc.  
•  Medical Management Olomouc, Ostrava, 
České Budějovice.
•  National Institute of Public Health 
•  Danish Graduate School in Public Health 
Science (13 institutions)
•  Centre for Applied Health Services and 
Technology Assessment
•  Danish Institute for Health Services 
Research
•  National Institute for Health 
Development
•  Estonian Academy of Sciences 
Country Ministry of Health
Ministry of 
Science
Foundations/ 
Regions Performers
Finland
France
Germany
Greece
Hungary
Ireland
•  Ministry of Health
•  Ministry of Social 
Affairs and Health 
•  French National 
Authority for Health 
•  French Agency for 
Environment and 
occupational health 
safety 
•  National agency 
for health, food, 
environmental and 
work safety)
•  The Federal Ministry 
of Health 
•  Länder (independent 
level of government)
•  Ministry of Health 
and Social Solidarity
 
•  Ministry of National 
Resources
•  State Secretary 
Department for 
Health
•  Department of 
Health and Children 
•  Health Research 
Board
•  Academy of Finland 
(Research Council 
for Health)
•  Tekes – Finnish 
Funding Agency 
for Technology and 
Innovation
•  Sitra - Finnish 
Innovation Fund 
•  National Research 
Agency
•  MiRe-DREES, 
Research mission - 
Research, studies, 
evaluation and 
statistics directorate 
•  The DFG, 
German Research 
Foundation 
(Deutschen 
Forschungsge-
meinschaft, jointly by 
Federal and Länder 
governments)
•  German Health 
Research Council 
•  Ministry of 
Education, Lifelong 
Learning and 
Religious affairs 
-General Secretariat 
for Research and 
Technology
•  Ministry of National 
Development
•  National Development 
Agency (manages 
the Research 
and Technology 
Innovation Fund)
•  Science Foundation 
Ireland 
•  Higher Education 
Authority 
Programme for 
Research in Third 
Level Institutions
•  France Foundation 
•  City, Regional or 
general councils 
•  French Institute for 
Rare Diseases 
•  France Alzheimer 
Association
•  National League 
against Cancer 
•  Association 
Française contre les 
Myopathies 
•  National Agency for 
AIDS Research 
•  Alexander-
von-Humboldt-
Foundation
•  Fraunhofer Society
•  Medical Research 
Charities Group 
•  National Institute for Health and Welfare
•  Finnish Office for Health Technology 
Assessment
•  National Centre for Scientific Research
•  National Institute of Health and Health 
Tesearch, 
•  National Institute of Prevention and 
Health Education 
•  Interdepartmental Mission for the fight 
against drugs and drug addiction 
•  National Cancer Institute 
•  Fraunhofer Society (with industry)
•  Helmholtz Association (health)
•  Max Planck Society
•  Leibniz Association
•  Bertelsmann Foundation
•  Robert Koch Institute,
•  Federal Centre for Health Education,
•  Federal Research Institute of Nutrition 
and Food’
•  Institute of Quality and Efficiency in 
Health Care
•  National School of Public Health
•  Centre for Disease Control and 
Prevention (KEEL-PNO)
•  The Hellenic Pasteur Institute 
•  Hungarian Academy of Sciences (one 
committee on Preventive Medicine)
•  National Institutions of the Hungarian 
National Public Health and Medical 
Officer Service
•  Institute of Public Health in Ireland
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Ministry of 
Science
Foundations/ 
Regions Performers
STEPS report: Public Health Research – Europe’s Future32
Italy
Latvia
Lithuania
Luxembourg
Malta
The Netherlands
Poland
Portugal
Romania
Slovakia
•  Ministry of Health, 
(annual Call for 
Researchers of the 
NHS) 
•  Ministry of Health 
•  Ministry of Health
•  Ministry of Health
•  Ministry of Health, 
the Elderly and 
Community Care
•  Ministry of Health, 
Welfare and Sport
•  Netherlands 
Organisation for 
Health Research 
and Development 
(ZonMW)
•  Ministry of Health, 
(Department for 
Research and 
Higher Education)
•  Ministry of Health 
•  Ministry of Health
 
•  Ministry of Health
•  Ministry of 
Education, 
University and 
Research, 
•  National Research 
Council
•  Latvian Council of 
Science
•  The Research 
Council of Lithuania
•  National Research 
Fund Luxembourg
•  Malta Council 
for Science and 
Technology 
•  Netherlands 
Organisation for 
Scientific Research
•  State Committee for 
Scientific Research 
•  FCT, Science 
and Technology 
Foundation 
•  National Authority for 
Scientific Research
•  Managerial Agency 
for Scientific 
Research
•  Ministry of 
Education, Science, 
Research and Sport
•  Scientific Grant 
Agency
•  Slovak Research 
and Development 
Agency
•  Agency of the 
Ministry of Education 
for the Structural 
Funds
•  Foundation for 
Polish Science 
•  Calouste Gulbenkian 
Foundation
•  Open Society 
Foundation
•  Institute for Occupational Safety and 
Prevention
•  National Institute of Health
•  National Agency for Regional Healthcare
•  Centre of Health Economics
•  Institute of Hygiene
•  Drug Control Department
•  National Health Laboratory 
•  Public research centre for health
•  Department of Health Information and 
Research
•  National Institute for Public Health and 
the Environment
•  Netherlands Institute for Health Services 
Research
•  TNO, knowledge for business
•  National School of Public Health
•  National Food and Nutrition Institute
•  Polish Academy of Science (76 
institutes)
•  R&D institutes funded by the Ministry of 
Health
•  National Institute of Health Doutor 
Ricardo Jorge
•  National School of Public Health
•  Institute of Public Health, University of 
Porto
•  National Institute of Research and 
Development in Pathology and 
Biomedical Sciences “Victor Babes”
•  Comenius University, Bratislava, 
•  Pavol Jozef Safarik University, Kosice
•  Slovak Medical University, Bratislava
•  University of Trnava 
Country Ministry of Health
Ministry of 
Science
Foundations/ 
Regions Performers
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Slovenia
Spain
Sweden
UK
•  Ministry of Health 
•  The Health 
Insurance Institute of 
Slovenia 
•  Ministry of Health 
and Social Policy
•  Ministry of Health 
and Social Affairs 
•  Swedish Council for 
Working Life and 
Social Research
•  Swedish Council 
on Technology 
Assessment in 
Health Care
•  Department of 
Health, Policy 
Research 
•  National Institute for 
Health Research
•  Devolved - Wales, 
Scotland, N Ireland
•  Slovenian Research 
Agency 
•  Ministry of Science 
and Innovation
•  Institute of Health 
Carlos III
•  Spanish National 
Research Council
•  The Centre for 
Research and 
Quality Control 
from the National 
Consumer Institute
•  (CICC, Instituto 
Nacional del 
Consumo,)
•  The Swedish 
Research Council 
•  UK Research 
Councils
•  Fundación 
Salud2000 
•  Fundación de 
Investigación Médica 
Mutua Madrileña 
Automovilista
•  Fundación MAPFRE 
Medicina 
•  Fundación Alicia 
Koplowitz 
•  Fundación para la 
investigación y la 
prevención del SIDA 
•  Fundación la Caixa 
•  Fundación BBVA 
•  Fundación Caja 
Madrid
•  Vardal Foundation
•  AFA Insurance
•  Wellcome Trust
•  UK Medical 
Charities
•  Kings Fund
•  Health Foundation
•  Nuffield Trust
•  National Institute for Public Health
•  9 Regional Institutes of Public Health
•  Biomedical Research Centre Network for 
Epidemiology and Public Health
•  CIBERESP (Consortium)
•  Centre for Public Health Research, 
Valencia
•  Agencia de Salud Pública de Barcelona 
•  Consorcio Parque de Salud MAR de 
Barcelona 
•  Centro de Investigación en 
Epidemiología Ambiental 
•  Swedish National Institute for Public 
Health
•  Nordic School of Public Health
•  Karolinska Institutet
•  Public Health Research Consortium
•  MRC Population Health Sciences 
Research Network
•  UK Clinical Research Collaboration
•  Public Health Research Centres of 
Excellence
Country Ministry of Health
Ministry of 
Science
Foundations/ 
Regions Performers
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5.2  Summary reports for the 12 EU new member states 
of meeting with ministry of health, and use of the 
Structural Funds (Full reports at www.steps-ph.eu)
Bulgaria
Czech Republic
•  3 February 2011 at the Information Centre of the 
European Union, Sofia. 34 participants - Ministry 
of Health, Ministry of Finance, academics, CSOs, 
business.  
•  Letters of support and thanks were sent by the Deputy 
Minister of International Affairs and Public Health, 
Desislava Dimitrova, and Chair of the Parliamentary 
Commission on Health Care, Desislava Atanasova.
•  A Forum for Public Health Researchers in Bulgaria was 
established. Others interested in collaboration in public 
health research included NGOs, general practitioners, 
social workers, patients forum and academia.
•  There are proposals to appoint a responsible officer in 
the Ministry for contacts with NGOs in public health, 
and a section on the Ministry website registering public 
health research activities in Bulgaria, were met with 
interest and understanding. 
•  The Ministry of Finance also asked to know more 
of the issues facing public health in Bulgaria, and 
to organise a working meeting in the ministry on 
problems of public health financing. 
•  13 April 2011. Meeting with 13 people, including 
researchers, ministry, WHO. 
•  Public health research has suffered as the three national 
institutions dealing with public health – Institute of Social 
medicine and organization of health care services, 
National centre for health promotion and Institute of 
health policy and economics – have been abolished. 
•  The Internal grant agency of the Ministry of Health 
has two subcommittees (Health and life conditions 
and Nursing, health care systems and informatics 
respectively) for public health research.  The Ministry 
of Health’s European Funds department has a 
sub-programme on prevention of health risks, and 
promoting healthy lifestyle.  But health promotion is 
strongly under-financed: two years ago there were 35 
million CZK (about 1.5 million €) available for these 
projects, while this year it is only 1 million CZK (about 
40 thousand €).  Similarly for HIV/STD prevention 
there is a drop from 60 to 3 million CZK. NGOs have a 
low success rate (eg 2 out of 16 applications). 
•  All participants considered that the institutional base of 
public health research ought to be re-established
•  The Grant Agency’s rules for awarding projects should 
be modified to increase the ratio of civic organizations 
gaining financial support from grants
•  The participants agreed to request the Deputy Minister 
and the Head of Public health department to concentrate 
on primary rather than secondary prevention, and 
supported the idea of authorizing a co-ordinator of public 
health research at the Ministry of Health.
•  The outcomes of the seminar were outlined in a 
press release distributed to media and a copy with 
recommendations was sent to Minister of health.
•  Bulgaria has a low level of research funding, 0.50% of GDP 
(2008). Some external research funds come from bilateral 
country grants, eg from Norway, Germany, Slovakia. 
Resources are allocated by the Ministry of Education, 
Youth and Science  (MEYS). In 2009, a National Research 
Board competition approved 84 ‘thematic’ proposals (7 in 
biosciences), 44 ‘ideas’ proposals, and three centres of 
excellence (engineering, agriculture and IT).  
•  The Structural Funds for 2007-2013 total €6.9bn. The 
seven Operational Programmes do not directly identify 
R&D. The fourth, Competitiveness, Axis 1.2 (€75m) 
beneficiaries includes “R&D institutions and organizations, 
municipalities, private or public bodies including NGOs”.  
Operational Programme “Regional Development” 
allocated €17 million for support/upgrading of universities.  
•  In 2007, 20 PhD/Post-doc appointments were 
made, 18 of which were to the Bulgarian Academy 
of Sciences.  In 2010, MEYS allocated €2.5m to 
‘encouraging the science-business dialogue; and 
‘qualification of young scientists working with high 
technologies’ (European Social Fund). 
•  Czech Republic has medium level investment in R&D 
at 1.6% of GDP, with public sector investment 38% 
and private sector 62%. 
•  As one of eight main themes in the Czech Republic 
€26bn Structural Funds 2007-2013, the Operational 
Programme Research for Development and Innovation 
has €2.07bn:  €685m (33%) for equipment and 
infrastructure for research, €685m (33%) for R & D 
institutes focused on applied research, strengthening 
their cooperation with industry (but including hospitals) 
according to the needs of the region. €213m (10%) for 
commercialization of R&D,  protection of intellectual 
property rights, and technology transfer, €414m (20%) 
for universities’ infrastructure of laboratories and IT, and 
€72m (3.5%) monitoring of projects and programmes, 
studies and analysis, programme publicity, and training 
and consultancy services.  A further operational 
programme for universities and Academies, funded 
through the Ministry of Education, Youth and Sports, 
provides €154m institutional support.
•  The programme Call 1.2 (2009) for Regional R&D 
centres had 18 successful applications, predominantly 
in technical engineering. In Nov/Dec 2010, biomedicine 
has been favoured with a €100m molecular genetics 
centre at Vestec near Prague for Charles University 
(the project coordinator is the former President of the 
Academy of Science) and a €12m Regional Centre of 
Applied Molecular Oncology at Brno. 
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Cyprus
Estonia
Hungary
•  15 March 2011 at University of Nicosia: 6 participants, 
including researchers, Ministry of Health, CSOs. 
•  The participants did not expect CSOs to be involved in 
research, but suggested that the government should 
come closer to volunteerism, so that the Civil Society 
Organisations would be guided on the issues and 
supported. 
•  Public health research was seen to benefit health 
professionals getting to know their patients’ point of 
view in terms of facing the disease and treating it, and 
in the support of the family environment. 
•  18 March 2011. Meeting with the Minister of Health
•  The Minister, Dr Christos Patsalides, was very 
interested in the actions by STEPS. He affirmed that 
the promotion of public health research is one of the 
main objectives of the Ministry of Health Medical and 
Public Health Care Services. Discussion focused on 
the promotion of public health research by academics 
and with the involvement of civil society organisations.
•  6th of April 2011 at Ministry of Social Affairs of Estonia. 
6 participants –including CSO, ministry, researcher. 
•  The discussions mainly addressed data collection, use 
and availability. 
•  Institutions in the public sector collect valuable data on 
health status, but the data are not sufficiently used for 
secondary analysis.
•  Information on public health activities and results 
are available on the webpage www.terviseinfo.ee 
(National Institute for Health Development).  Cross-
reference with other web-pages would help to find the 
information, and CSOs need to learn how to access 
this information.  
•  Health profiles compiled by counties will provide 
plenty of information on health on the county level. 
International co-operation through EU projects is also 
desirable.
•  14 February 2011 at Ministry of National Resources, 
Budapest. 14 participants – CSOs, researchers, ministries. 
•  “Research into public health has been pushed to 
the periphery of the Hungarian scientific research 
system, and its institutions are fragmented. Clearly 
defined priorities and co-ordination supporting them 
are missing. The prestige of this subject field is low, 
strikingly under-financed and its political acceptance is 
also limited.”
•  It is important to create an efficient, uniform and co-
ordinated system for research into public health, and 
to eliminate its undervaluation as compared with bio-
medical research. 
•  Research data collected with public funding should be 
made available to the civil sector.
•  Cyprus has low expenditure on R&D at 0.49% 
(2009). Cyprus has three private universities and no 
medical school (one is developing in north Cyprus). 
Of €83m R&D funds, 45% (€38m) was directly from 
government, €19m from the universities’ budgets, 
€10m from abroad (€8m from EU) and  €16m from the 
private sector (€5m pharmaceuticals).
•  Cyprus has €640m Structural Funds, organised in two 
Operating Programmes (ERDF and ESF respectively). 
RTDI has been implemented through the Cyprus 
Research Promotion Foundation. There have been 
two National Research Frameworks (DESMI) - in 
2008 €48m, and for 2009-2011 €40m. These were 
allocated: €33.4m for natural sciences, €16.6m 
social sciences, €14.6m engineering and technology, 
€10.2m agricultural sciences, €5.1m humanities, 
€3.2m health and biological sciences (including public 
health research).  Other State support for biomedical 
research includes €5m annually for Cyprus Institute of 
Neurology and Genetics (University of Nicosia).
•  R&D in Estonia has grown from 0.6% of GDP in 2000 
to 1.4% in 2009. Spend is 39% natural sciences, 19% 
engineering, humanities, 15% medical and health 
sciences, 12% humanities, 9% social sciences, 5% 
agricultural sciences. 
•  Over 2007-2013, Estonia receives €3.4bn Structural 
Funds - ERDF €1.86bn, Cohesion Fund €1.15bn, and 
European Social Fund €390m.
•  ERDF supports €306m for infrastructure and 
development of institutions. Also, small-scale research 
equipment, an application round for supporting R&D 
in biotechnology, several targeted R&D supporting 
programmes and a programme for supporting 
international collaboration.
•  Operational Programme for Human Resource 
Development, operated by the Estonian Ministry 
of Education and Research receives €102m euros 
(plus €14m state co-funding).  Programmes include 
Mobilitas, supporting postdoctoral research (€20m 
euros), implemented by the Estonian Science 
Foundation (five rounds of calls for ‘top researcher 
grants’), and state’s Archimedes Foundation funding 
internationalization of doctoral studies (€32m).  
•  There is a low rate of research investment in Hungary 
at 1% of GNP, which is 52% from private sector and 
45% from public sector (including Structural funds). 
•  The Structural Funds (€22.4bn) are allocated 
through 15 Operational Programmes of the National 
Development Plan. RTDI activities are mainly supported 
under the Economic Development Operational 
Programme (EDOP).  Priority 1 “R&D and innovation for 
competitiveness” has €822m over 7 years from ERDF.  
Under the Priority 1, R&D projects and investment 
are seen across three fields: the promotion of market-
oriented R&D; innovation clusters and technology parks; 
and R&D activities by enterprises. 
•  The Social Infrastructures Operational Programme, 
supports research and educational infrastructure at 
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Hungary (cont.)
Latvia
Lithuania
•  Measures should be taken to have the priorities 
of public health research financed on the basis of 
uniform principles, hand in hand with the monitoring 
and evaluation requirements of the public health 
programme. 
•  Organizational guarantees are needed to ensure the 
participation of NGOs in the bodies managing public 
health research, including adequate operating costs.
•  25th of January, 2011 at Ministry of Health. 25 people 
– CSOs, Ministry of Health, academics.  
•  The importance and application of evidence-based 
information in public health practice and public health 
research problems in Latvia were discussed. CSOs 
wished to participate in, or to support, public health 
research in Latvia in order to create evidence based 
public health practice: the main obstacle was a lack of 
financial and human resources. 
•  The Latvian Public Health Association is a principal 
organization for consulting in public health research. It 
would be possible to organise an annual seminar for 
CSOs on public health issues and training to facilitate 
the collaboration.
•  The Ministry of Health representatives agreed that 
biomedical research is often granted under the label 
of “public health research”. There is no separate 
allocated budget for public health research in Latvia. 
The only state institution under the Ministry of Health 
is the Centre of Health Economics. However, there 
is also lack of human and financial resources for 
implementing active public health research. 
•  The situation will be changed. Following the 
recommendations from EU and initiatives of the 
Ministry of Health, the Ministry of Science and 
Educations agreed that the research strategy in clinical 
and public health research will be developed by the 
Ministry of Health, in relation to allocation of resources 
for research from year 2014. 
•  The Ministry of Health has no structure or contact 
person responsible for managing and coordinating the 
public health research system in Latvia, but is aware of 
the need for  coordinating both public health and also 
intersectoral research. 
•  A working group on public health research under the 
guidance of the Ministry of Health would be beneficial, 
and also for collaboration at European level for 
implementing and developing public health research 
system. 
•  The National Strategy for Public Health Care for 2006-
2012 lists public health research as one of the ways 
towards the implementation of public health objectives. 
The Public Health Care Law also lists scientific 
research as the means of improving the quality of 
public health. 
•  However, public health research in Lithuania is 
placed at the margins of overall research and it is not 
identified as a separate research area, which results 
in the lack of clarity in coordinating, implementing and 
financing public health research. 
higher education institutes, and the Social Renewal 
Operational Programme for collaborative RTDI, 
including basic research. Together with EDOP, these 
have more funds than the main national Research and 
Technological Innovation Fund.
•  Latvia has a low rate of research, 0.61% of GDP 
(2008), but research and development have been 
supported as a national priority, linked with the 
Structural Funds, which have  made ‘notable’ 
allocations to Science 6% (€268m), education 10% 
(€444m) and entrepreneurship and innovation 11% 
(€495m).
•  The Ministry of Education and Science Programme 
2006-2009 had nine priority areas, including (bio) 
‘medical’ sciences. There are five  state programmes 
for 2010–2013, of which the fourth is “public health”. 
•  ERDF  2.1 Priority “Science and Innovation” has 
€451m, which includes “Science, Research and 
Development” (€50m) for investigator-initiated 
proposals.  In a call in 2010, from 177 proposals 
114 were financed.  A second activity “Development 
of the scientific and research infrastructure” covers 
infrastructural development in 10 National research 
centres and the development of scientific computing 
network with total ERDF support €175m.  Among these 
10 centres is the national research centre in public 
health and clinical medicine.
•  In the 3rd operational programme “Infrastructure and 
Services” (ERDF/CF), €168m is given to development 
of infrastructure for higher education, including large 
equipment. Activity “Development of Science and 
Technology park of Riga”, originally intended to 
support biomedical research, has been put on hold 
because of absence of suitable land for development, 
as a consequence of privatisations.
•  The measure “Health Care Infrastructure” in the Health 
part of the Structural Funds is purely infrastructural; no 
support is planned for research activities. 
•  Lithuania has a relatively low level of research at 
0.82% of GDP in 2007, coming from public support 
(48%), foreign (20%) and business (25%).  
•  The annual Structural Funds for Lithuania 2007-2013 
are €1 billion, around 15% of the total national budget. 
Planning with stakeholders was developed from 2005. 
Support for research and innovation is well-developed 
under all three priority areas. 
•  Operational Programme 1-3: ‘Enhancement of 
researchers’ capacities’, coordinated by the Ministry 
of Education and Science, includes development of 
Country STEPS meeting with ministry of health Research and the Structural Funds
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Lithuania (cont.)
Malta
Poland
•  Public health research is mostly conducted through 
state institutions or academic institutions. NGOs and 
the private sector have difficulty participating in it.
•  Access to information about the existing research, its 
results and the use of findings is limited to a narrow 
scientific audience and/or to internal communication 
channels within public institutions. NGOs and the 
public have difficulty knowing what research is being 
conducted, what the priorities and the findings of 
research are. 
•  Coordination is the key problem. There is no one 
institution or one official that could oversee the 
coordination of public health research between 
institution and other stakeholders. There is also no 
body or mechanisms that would help set priorities for 
public health research.
•  The Vice minister agreed that public health research 
and its coordination is important for improving the 
quality of public health. He stated that a larger role 
should be played by the reformed public health centres 
that exist or will exist in almost each municipality. He 
also mentioned the Centre for Health Education and 
Disease Prevention as a possible actor in the field. 
•  Within the Ministry of Health, the Department of Public 
Health is responsible for public health matters, and the 
Vice minister did not identify another coordinating person 
at the ministry charged specifically with research.
•  Friday 25 February 2011.  Department of Health 
Information and Research within the Ministry of Health, 
the Elderly and Community Care. 3 people present.
•  Following the STEPS national workshop, Malta Council 
for Science and Technology has initiated a process 
towards a national health research strategy. Focus 
groups have been established for different research 
strands, including one with a ‘social, psychological and 
behavioural’ focus .
•  There is an officer responsible for public health 
research within the Ministry of Health, the Elderly and 
Community Care. 
•  [No meeting could be arranged with the Ministry of 
Health in the second phase of STEPS. The information 
below was collected during first phase visits]
•  The Ministry’s Department for Research and Higher 
Education, and Scientific Council for the Ministry has 
a budget to fund small research projects (1-2 years), 
scientists and researchers, thematic networks and 
R&D training (€140m). 
•  Operational programme 2.1: ‘R&D for competitiveness 
and growth’ has €602m, includes infrastructure 
projects, ‘high level research centres’, business parks 
and integrated studies
•  Operational Programme 3.2:  Priority 1.4 
Strengthening of Administrative Capacity and Increase 
of Efficient Public Administration (€178m) includes 
Priority 1-4.3 (€37m), which integrated science, 
study and business centres (valleys), joint research 
programmes, strengthening the Lithuanian Scientific 
Council, and the development of monitoring of science 
and studies. 
•  Public health activities supported by this last measure 
include the analysis of public health care carried out 
by municipalities, studies to identify the scope of public 
health services, the development of a monitoring 
system, creation of models for providing public health 
services, training and professional development of 
public health care specialists, creation of a demand 
planning system as well as improvement and 
development of public health impact assessment. Other 
activities cover the analysis and improvement of the 
legal base for management of the Lithuanian national 
health system in health emergency cases, improvement 
of management of information exchange about health 
emergencies, studies and analysis aimed at improving 
management of public health risk factors, improvement 
of the legal base, creation of methodologies, 
recommendations, activity algorithms and monitoring 
models, research into the areas of preventive planning; 
issues of healthcare quality assurance and assessment 
of healthcare technologies. 
•  In 2007, Malta spent 0.6% of GDP on research and 
development. However, business contributed the 
largest proportion of funds with €21m. (65%) (largely 
multinational firms undertaking in-house R&D), 
followed by higher education €10m (31%), with public 
research organisations just €1m (3.3%). 
•  Malta’s Structural and Cohesion Funds for 2007-
2013 total €855m. Just under 10% is allocated to 
‘Knowledge & Innovation’, mainly for infrastructures 
(eg the IT faculty at the university, strengthening 
university laboratories in engineering, biotechnology 
and chemistry, 49m). Malta Enterprises, an agency 
working under the Ministry of Finance, will receive 
€20m for a Life Sciences Centre (molecular genetics) 
€20m. An Educational Pathways Scholarship Scheme 
for Post-Graduate studies (MSc, PhD) is established 
with €10m, and Centre for Policy Research and 
Training for the Public Sector €3.4m.  
•  The research expenditure in Poland is low at 0.61% of 
GDP in 2008. It is heavily reliant on non-competitive 
public funding through a large number of higher 
education institutes and academies.  The State budget 
provides three fifths of research funds (€1.07bn), 
and the business sector one quarter expenditure. 
Country STEPS meeting with ministry of health Research and the Structural Funds
STEPS report: Public Health Research – Europe’s Future38
Poland (cont.)
Romania
activities implementing previously-demonstrated 
successful studies, and an on-line medical library.  
The Ministry supports 17 R&D institutes, including 
the national institute of public health, occupational/
environmental health, as well as clinical institutes.  
•  Clinical research can overlap with public health, 
for example the Warsaw Institute of Oncology has 
led initiatives in tobacco control, and the Institute of 
Neurology and Psychiatry has undertaken research on 
stroke units, registers and monitoring care. There are 
also NGOs established to support specific diseases. 
•  The Ministry has held meetings to increase 
participation in 7FP, as well as seminars in universities 
for young scientists.  The Structural Funds are 
regarded as ‘not for research’, although there is an 
office for Structural Funds within the Ministry for 
healthcare projects.
•  Neither the Ministry of Education nor the Academy 
of Science institutes support public health research. 
A National Centre for R&D ‘holds funds for research 
and administers grants’, but these are only in the 
area of technology.  However, an open day on the 
3rd FP7 Health call held by the Institute of Advanced 
Technology, an FP7 agency for FP7 within the 
Academy funded by the Ministry of Science,  had 
‘huge interest’ – over 100 – people from medical 
universities, health foundation, NGOs. 
•  11 March 2011. Ministry of Health – Deputy General 
Secretary’s Office. 8 participants – Secretary of State, 
Ministry of health, academics. 
•  The Ministry of Health’s reform of the health system 
(decentralization, reclassification of hospitals, new 
contracts with providers and reforming the national 
health programs) shows a strong need for evidence for 
the new health policies. The Ministry recognizes the 
importance of the public health research and the need 
for it.
•  While collaboration with the Ministry of Education and 
Research is good, the Ministry of Health’s involvement 
in research is quite weak. Equally, while there are 
many opportunities available at EU level, Romania still 
doesn’t use them very well.
•  MoH supports public health research and is willing to 
encourage the national stakeholders to do research in 
health field, including public health. MoH will analyze 
what actions are needed to increase the visibility of 
health research, especially in public health field.
Significant funding has been earmarked for research 
infrastructure. 
•  The Structural Funds for Poland 2007-2013 are €67.3 
billion, the largest for any member state, allocated in 
four main programmes.  The smallest, the Operational 
Programme Innovative Economy, has €8.85bn from 
ERDF. There are two research-related programmes: 
‘Research and development of new technologies’ 
(€1.1bn) covering informatics, technologies and 
biotechnologies (includes ‘new medical products and 
techniques’), and ‘Infrastructure of R & D’ (€1.1bn) for 
science organisations, higher education institutes and 
computing’.
•  The Operational Programme Infrastructure and 
Environment (€27.9bn) includes Priority 12 ‘Health 
security and improving the efficiency of the health 
system’ (€350m from ERDF), although this is not 
related to research. Priority 13, ‘Infrastructure of higher 
education’ (€500m from ERDF) covers infrastructures, 
access and improving the quality of education  
through IT.  
•  In the Human Capital Programme (€9.7b) is Priority 
4.2, ‘Developing R&D staff qualifications and 
increasing awareness of science importance to 
economic growth’ (€61m).
•  Regional Operational Programmes (€16.6bn) have 
been created for each of the 16 provinces. Some 
Regional Innovation Strategies include innovation 
networks and R&D. http://www.pi.gov.pl/eng/
chapter_86528.asp
•  Romania has a low level of R&D investment, 0.58% 
of GDP in 2008, with proportions 42% by the private 
sector, 40% by the government sector and 24% by 
higher education. There is growing use of competition 
in public funding of research, and of the structural 
funds to support research, although there were 
substantial public budget cuts in 2009.  
•  Romania gains €19.6bn from EU Structural and 
Cohesion Funds. Funded by ERDF, the Operational 
Programme “Increase of economic competitiveness” 
includes Axis 2: Research, Technological Development 
and Innovation for competitiveness (€536m), which is 
managed through the National Authority for Scientific 
Research and addresses five of the nine priorities of 
the national RDI strategy, including (first) ‘Health’. The 
sub-sections are: ‘2.1: R&D partnerships between 
universities, institutes and enterprises’; 2.2: Investment 
for RDI infrastructure; 2.3 Enterprises’ access to 
RDI activities, products and processes. It is being 
implemented through competitive calls. A call in 2011 
for ‘Promoting innovation in enterprises’ (Section 2.3) 
had a budget of €200m.  
•  The Operational Programme ‘Human Resources 
Development’ funded by ESF, has Axis 1 with 
€797m for higher education, and includes University 
education for the knowledge society’ and ‘Doctoral and 
postdoctoral programmes in support of research’. 
Country STEPS meeting with ministry of health Research and the Structural Funds
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Slovakia
Slovenia
•  4 April 2011, at the Office of the Chief Public Health 
Officer with 11 participants
•  National public health research financing was pointed 
out as crucial for the future. Conditions given in 
national calls, and process of evaluation of applications 
from perspective of quality and transparency, were 
mentioned. 
•  An electronic communication with selected 
stakeholders was also realised from middle of April 
to end of May 2011 (Ján Porubský, Deputy Minister 
of Health, and 7 other senior members of official 
committees)
•  The new Chief Public Health Officer confirmed 
his participation at the 4th national public health 
association conference in Kosice June 2011, where 
the issues were further discussed in an international 
session. 
•  [No meeting held with the Ministry of Health - 
information collected during first phase visits]
•  Research in Slovenia is managed through the 
Slovenian Research Agency (ARRS). The Agency 
spends about 10% of its funds – €18m out of €180m – 
on medicine, compared with 27% on engineering and 
24% on ‘natural sciences’.
•  About 50% funds go to the 15 public institutes, and 
most of the rest to the four universities (Ljubljana, 
Maribor, Nova Gorica, Primorska): medicine research 
is mostly funded to Ljubljana.
•  The Ministry of Health has a budget of 350 000 euro 
that it transfers to ARRS for research for two fields 
– clinical (‘applicative’) and public-health (‘goal-
oriented’). In 2008 there were 14 proposals approved 
in clinical research and 8 in public-health. 
•  Priorities for research are developed within the 
Ministry’s public health department, in discussion with 
National Institute for Public Health and universities, 
and sent to ARRS where they are further refined and 
processed for competitive calls. Recent topics have 
included flu, depression in primary care, genetic 
causes of obesity, drug misuse (with NGOs), and 
adolescent mental health.
•  The Ministry of Health has an officer with formal 
responsibility for health research, who has liaison with 
both the Institute of Public Health and the Slovenian 
Research Agency, and is also a national representative 
on the FP7 Health programme committee.
•  Slovakia’s well-established R&D system was low at 
0.5% of GNP in 2007. However, R&D is the main 
thrust for the 2007-2013 Structural Funds, with €1.2 
bn allocated for the Research and Development, 
€883m for Convergence, and €326m for Regional 
Competitiveness and Employment.
•  The R&D operational programme is aimed at 
“modernization and increase of effectiveness of the 
support system for research and development and 
improvement of universities’ infrastructure” Over €500m 
was put out to 13 calls in 2009, which included grants 
for research of around €1m each (including clinical 
research studies), for ‘centres of excellence’ of around 
€4m (including environment and health, stroke and 
perinatology), and grants for SMEs, including several for 
biomedical technology. (http://www.asfeu.sk/operacny-
program-vyskum-a-vyvoj/zoznam-prijimatelov-nfp)
•  The Operational Programme Education, also under the 
Ministry of Education, has a total of €617m. It includes 
Measure 2.1, support for tertiary education (€28m in 
2009 call), as well as Measure 2 2 ‘Support for life-long 
learning in the Health sector’.  Calls for ‘Rehabilitation 
and construction of technical infrastructure for R & D’ 
offered €149m in 2010. 
•  The third Operational Programme, Competitiveness 
and Economic Growth, has one thematic programme 
for universities’ buildings and infrastructures. This sub-
programme is under the Ministry of Education and has 
a budget of €1.2bn 
•  Slovenia has a medium level of investment in R&D 
at 1.6% of GDP in 2008 (business sector 59% 
(particularly pharmaceuticals and machinery), 
government sources 29% and sources from abroad 
6%). “The majority of resources will not be directed 
towards basic research but focused on technology 
development, R&D activities in business sector and for 
stimulating investment in new production facilities in 
high-technology area.”
•  The total EU Structural Funds are €4.2bn, divided into 
five programmes. The first of these, Strengthening 
Regional Development Potential has €1.7m (40%), 
with five operational programmes, of which the first 
‘Competitiveness and Research Excellence’ receives 
€402m (24%). The activities envisaged include centres 
of excellence, interdisciplinary R&D projects and 
investments in the modernisation of R&D equipment. 
•  In the planning proposal (2007) for ‘Competitiveness 
and Research Excellence’, there will be support for 
900 private RTD projects (predominantly in SMEs), 
and links to centres of excellence. In a competitive 
call for 2009-2013, eight Centres of Excellence for 
infrastructures programmes and operation were 
chosen (out of 60 applications), each receiving €10m: 
all were in technology, with one in biochemistry. Seven 
Competence Centres received €7m each, with one in 
biotechnology and one in biomedical engineering.
Country STEPS meeting with ministry of health Research and the Structural Funds
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5.3  STEPS workshop reports (Full reports at www.steps-ph.eu)
Petko Salchev, Lidia Georgieva, 
Club Economica 2000
Constantinos N. Phellas, Christina 
Loizou
Research Unit in Behaviour  and 
Social Issues, University of Nicosia
Kateřina Ivanová
Healthy Cities of the Czech Republic
Gerli Paat, Annika Veimer, Ülle 
Rüüson, Mairi Jüriska, Kristi Lokko 
PRAXIS Centre for Policy Studies
Zsuzsanna Füzesi, László Tistyán, 
Katalin Szőke
Fact Foundation
Anita Villerusa, Anda Karnite, Inese 
Gobina
Latvian Public Health Association
Jurga Poškevičiūtė
“I Can Live” Coalition
Nicola Critien
SOS Malta
Krzysztof  Krajewski-Siuda, Krzysztof 
Kaczmarek
Zakład Polityki Zdrowotnej
Silesian University of Medicine 
Florentina Furtunescu, Dana 
Fărcășanu, Dana Mincă, Letiția 
Stănilă, Cornelia Matic.
Centre for Health Policy and Services, 
National Institute of Public Health
Zuzana Katreniaková, Jana 
Potúčková, Iveta Rajničová-Naygová
Slovenian Public Health Association 
(SAVEZ)
Maja Zorko, Matej Košir, Dr Tanja 
Kamin, Sandra Radoš Krnel, Agata 
Zupančič
Slovenian National Institute of Public 
Health and Institute for Research and 
Development
STEPS ɜ Ȼɴɥɝɚɪɢɹ
Report on National Workshop in Bulgaria
ǹȞĮșȠʌȐ ȘȠȢ ǻșȞȚțȠȪ ǻʌȖĮȗȘȘʌȓȠȢ ȗȘȘȞ 
ȀȪʌʌȠ
Report on National Workshop in Cyprus
Souhrnná zpráva ze semináře „Podpora 
výzkumu v oblasti veřejného zdraví“ (Aktivní 
zapojení občanské společnosti do podpory 
zdraví v ČR)
Report on National Workshop in Czech 
Republic: Active engagement of the civil 
society in health support in the Czech 
Republic
Raport riikliku töötoa kohta Eestis
Report on National Workshop in Estonia
Beszámoló a nemzeti workshopról
Report on National Workshop in Hungary
Projekta tehniskais ziƼojums
Report on National Workshop in Latvia
Nacionalinio seminaro Lietuvoje ataskaita
Report on National Workshop in Lithuania
Report on National Workshop in Malta
Raport z realizacji krajowych warsztatów 
projektu STEPS
Report on National Workshop in Poland
Raport provind atelierul na܊ional 
Report on National Workshop in Romania
Správa z národného workshop na 
Slovensku
Report on National Workshop in Slovakia
Poročilo nacionalnega srečanja v Sloveniji
Report on National Workshop in Slovenia
http://www.steps-ph.eu/wp-content/uploads/Bulgaria_
Publication-steps-bg-08-07.pdf
http://www.steps-ph.eu/wp-content/uploads/Bulgaria_
November_2010_ENG.pdf
http://www.steps-ph.eu/wp-content/uploads/Cyprus_report_
NOV_2010GK.pdf
http://www.steps-ph.eu/wp-content/uploads/Cyprus_report_
NOV_2010Eng.pdf
http://www.steps-ph.eu/wp-content/uploads/Czech_
REPORT_NOV2010_CZECH.pdf
http://www.steps-ph.eu/wp-content/uploads/Czech_
REPORT_NOV2010_ENG.pdf
http://www.steps-ph.eu/wp-content/uploads/Estonia_report_
NOV2010_EST.pdf
http://www.steps-ph.eu/wp-content/uploads/Estonia_report_
NOV2010_ENG.pdf
http://www.steps-ph.eu/wp-content/uploads/Hungary_report_
NOV2010_HU.pdf
http://www.steps-ph.eu/wp-content/uploads/Hungary_report_
NOV2010_ENG.pdf
http://www.steps-ph.eu/wp-content/uploads/Latvia_report_
NOV2010_LAT.pdf
http://www.steps-ph.eu/wp-content/uploads/Latvia_report_
NOV2010_ENG.pdf
http://www.steps-ph.eu/wp-content/uploads/Lithuania_
report_NOV2010_LT.pdf
http://www.steps-ph.eu/wp-content/uploads/Lithuania_
report_NOV2010_ENG.pdf
http://www.steps-ph.eu/wp-content/uploads/Malta_report_
NOV2010_ENG.pdf
http://www.steps-ph.eu/wp-content/uploads/Poland_reports_
Nov_2010_PL.pdf
http://www.steps-ph.eu/wp-content/uploads/Poland_reports_
Nov_2010_ENG1.pdf
http://www.steps-ph.eu/wp-content/uploads/Romania_
report_NOV2010_ROM.pdf
http://www.steps-ph.eu/wp-content/uploads/Romania_
report_NOV2010_EN.pdf
http://www.steps-ph.eu/wp-content/uploads/Slovakia_report-
NOV2010_SK.pdf
http://www.steps-ph.eu/wp-content/uploads/Slovakia_report-
NOV2010_EN.pdf
http://www.steps-ph.eu/wp-content/uploads/Slovenia_report_
NOV2010_SLV.pdf
http://www.steps-ph.eu/wp-content/uploads/Slovenia_report_
NOV2010_ENG.pdf
Authors and Organisation Title Reports STEPS Web pages
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6.  STEPS –  
the study
The purpose of STEPS has been, as its long 
title indicates, ‘Strengthening Engagement 
in Public Health Research’. It has addressed 
geographical inequalities by focusing its 
initial workshop activities in the 12 EU new 
member states where health levels and 
research systems are weaker, and where 
the best use of EU Structural Funds could 
significantly improve public health research 
and practice. It has identified leaders in the 
12 new member states and fostered national 
public health associations and actions 
for health research. And it has brought 
these initiatives together at European 
level, to disseminating findings for policy 
development in health research in Europe 
and to develop awareness of public health 
research in support for the Innovation Partnership on Active and Healthy Ageing.
STEPS is a Support Action that was proposed in response to a call from the 
Science in Society theme of the EU’s Seventh Framework Research Programme. 
The Call was for ‘Civil society organisation (CSO) capacity-building in research’. 
STEPS built on previous work which had shown the relative lack of support at both 
national and European levels for public health research compared with biomedical 
research, and also the weaker performance in public health research of the EU 
new member states. To meet these challenges, STEPS sought to raise the profile 
of CSOs and public health research in Europe.
STEPS was initiated and coordinated by University College London (UCL), working 
closely with the European Public Health Association (EUPHA), which represents 
national public health associations. A third partner with special expertise towards 
CSOs was Skalbes, a mental health CSO in Riga, Latvia. As STEPS progressed, 
country partners in each of the twelve new member states were also included, 
representing social research organisations (Bulgaria, Estonia, Hungary), health 
promoting organisations (Czech Republic, Lithuania, Malta, Slovenia), public health 
institutes and units (Cyprus, Poland, Romania,) and public health associations 
(Latvia, Slovakia).
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Methods of working
In the first phase, the STEPS principal partners took on the task of identifying lead 
organisations in the 12 new member states. In the European perspective, a civil 
society organisation is ‘a legal entity which is non governmental, non profit, not 
representing commercial interests and pursuing a common purpose in the public 
interest’. The organisations, both national public health associations and civil 
society organisations, were sought on the basis of having a variety of perspectives, 
and officers responsible for research policy in national ministries were identified. 
Visits of several days each were made to the twelve countries, and reports 
provided initial assessments of structures for public-health research. The project 
identified a lead in each country that would be interested in, and capable of, 
providing leadership for the workshops. The European Commission advised that 
the lead organisations should become full partners of STEPS, so that they would 
be able to dispose the resources for the workshops properly. This process of new 
registration and contracting was achieved by the end of the first year of the project.
STEPS worked to build a collective view of public health research both between 
the CSOs in new member states and also at European level. The focus on new 
member states gives prominence to the countries with more recent entry to the 
EU; the assessment at European level provides an overview from representative 
organisations. The initial search for CSOs to hold the STEPS national workshops 
sought to include both health civil society organisations from a range of different 
fields, and also national public health associations that were members of the 
European Public Health Association (EUPHA). Earlier work by the European Public 
Health Alliance (EPHA), in Brussels, provided leads for contacting CSOs in the new 
member states, while the EUPHA member associations also provided entry.  
Finding partners to lead STEPS at national level required persistence and 
encouragement, since not all the countries have members in EPHA, and it is 
individuals rather than organisations that participated in EUPHA at the annual 
conference and as researchers.  The twelve CSO partners finally included two 
national public health associations, five university departments, four generalist 
CSOs and one health CSO.
The meetings 
undertaken in 
STEPS had 
the purpose of 
increasing 
awareness of 
public health 
research in 
each of the 
12 countries, 
with a particular 
emphasis on the 
contribution of 
civil society.
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The meetings undertaken in STEPS had the purpose of increasing awareness of 
public health research in each of the 12 countries, with a particular emphasis on 
the contribution of civil society. National public health associations fall within the 
EU definition of civil society organisations, being non-governmental, not-for-profit 
and working within the public interest.  However, they are generally created and 
supported by voluntary subscription of members, and are members of EUPHA. 
Other CSOs have a different model, usually gaining funds from public fund-raising, 
and with members of the public working as volunteers. Some of these, especially 
when campaigning, regard themselves as ‘non-governmental organisations’ – 
NGOs – although it is legally possible to be an NGO which represents commercial 
interests, or for commercial funds to support the NGO (patient associations and 
indeed medical associations may use this model in relation to the pharmaceutical 
industry that makes relevant drugs). 
The STEPS workshops sought to bring together organisations at national level 
concerned with health. There is no standard design of CSO, and while some 
countries in Eastern Europe previously set up national registers to track the legal 
status and governance of NGOs making applications for public funds, these are 
mainly poorly maintained. The STEPS country partners therefore had the challenge 
of finding health CSOs themselves within their countries.  
The partners came together for a first meeting in November 2009 in Lodz, Poland. 
The tasks for the workshops were discussed, and the partners decided that country 
surveys of CSOs would help identify those that had interests related to STEPS. A 
short questionnaire was created and translated by the country partners into their 
own languages. The surveys were undertaken in local languages in 8 countries, 
and summaries of the responses from the countries were then provided in English.  
The European-level component of STEPS drew on the existing networks of 
CSOs through the European Health Policy Forum, established by the European 
Commission’s Directorate for Health and Consumers. Contacts were identified for 
16 organisations that were members of Forum and that fulfilled the criteria of CSOs 
– excluding governmental organisations, and those with connections to industry. 
Replies were gained from 13 of the 16 organisations.
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The country workshops and reports
The country workshops were developed in similar format in each of the countries.  
There was initial preparation with a management group, and assessment of the 
interest of civil society organisations and national stakeholders. A single day event, 
with four introductory speakers followed by a broader discussion, was chosen. One 
of the topics was to address research in a specific field relevant to civil society health 
organisation activity. The workshops were held in the national language so that it 
could more easily reflect national concerns, while the findings could be translated 
and brought together for European interpretation in the second phase of STEPS. 
Workshop reports in both national languages and English were an important output 
of the first phase of STEPS, and after stylistic and content revisions, the finalised 
workshop reports were published on the project web page (www.steps-ph.eu). 
Surveys of CSO perceptions of research
Surveys to explore the perceptions of CSOs were made in two ways. In eight of the 
countries, the lead organisations identified and surveyed other national civil society 
organisations, in preparation for the country Workshops. This yielded 124 replies 
and provided perspectives of the broad interest of CSOs working with researchers 
and using knowledge for their work.
A survey was also made of perspectives of European civil society organisations 
in 13 member organisations that were members of the European Health Policy 
Forum (which is created by the European Commission’s Directorate for Health 
and Consumers). The majority of organisations at European level had links with 
researchers and valued the knowledge gained both for policy development and in 
support of their organisational strategies and innovation.
Public health research country profiles
To explore public health research in the 12 EU new member states, a mapping was 
undertaken of the structures for health research across the whole EU.  At present, 
the European Commission reports on member state research at composite level 
(through ERAWATCH), but not by discipline or field; and coordinating bodies such 
as the European Science Foundation do not have details across all countries. 
A major difficulty for health research is that ministries of science and ministries 
of health do not discuss research sufficiently at national level, and therefore 
information on national activities arriving at European level is partial. Equally, 
finding a national informant who understands the full range of health research 
within a country is challenging. STEPS therefore used the internet (with Google 
Translate) to build up national information according to a standard template, and 
then identified national advisers to correct and extend these reports. 
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Website
A website was developed at www.steps-ph.eu, with project news and a database. 
This included (1) the country workshop reports (2) the research country profiles (3) 
the reports on final meetings with ministries of health (4) other project publications. 
Structural Funds
In STEPS, it became apparent that the Structural Funds were being used in the 
12 new member states to support research and innovation. To address this issue, 
information was sought from web sites, through meetings (European Committee 
of the Regions) and through the partners. The data are not clear, as the structural 
funds are distributed by the European Commission but their allocation in actual 
projects is decided by member states, with different standards of reporting. More 
than €80 bn are allocated for research in the period 2007-2013, for activities 
including building universities, supporting postgraduate students, encouraging 
return of researchers from overseas, building science parks, supporting innovation 
in industry, and – in some countries – direct support for research. It has only been 
possible to track a very small number of these activities related to support for public 
health research.
International dissemination
The national workshops have promoted engagement of civil society organisations 
and public health research within the 12 EU new member states.  STEPS has 
been presented at the scientific conferences (2009-2011) of the European Public 
Health Association held respectively in Poland, the Netherlands and Denmark, and 
at the international conference on Health Services Research at The Hague, April 
2010. STEPS contributed to the EC Directorate for Health and Consumers meeting 
on the Public Health Programme in Menorca, Spain, September 2010, and has 
contributed at national meetings in Denmark, Malta, Slovakia and UK.
STEPS has also had multiplier effects impacts across European research fields:
•  STEPS has worked with the Council for Health Research for Development 
(COHRED), contributing to joint work on engaging civil society organisations 
in research as well as the Global Forum for Health Research (2009) and the 
Global Symposium on Health Systems Research (2010)
•  STEPS contributed to the international health agenda through meetings on 
health research commissioning for the Middle East (EuroMed), Africa (CAAST) 
and India (LSE/India programme).
•  The Slovak Public Health Association (SAVEZ) gained a Visegrad countries’ 
grant to hold a regional meeting in Kosice, Slovakia, in June 2011, 
•  STEPS has contributed to FAHRE (Food and Health Research in Europe), a 
project in the Seventh Framework Research Programme ‘Knowledge-Based 
Bio-Economy’, which has described national structures and themes for food and 
health research, and contributed to the joint programming on food and health
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European event and consultation on innovation
The final period for STEPS coincided with the consultation by the European 
Commission on funding for Innovation and Research in anticipation of the future EU 
budget 2014-2020. To promote the importance of public health research, on 2 May 
2011 the project partners from the 12 EU new member states partners visited their 
national representation offices in Brussels and talked to the attaché for research; 
they met with the European Commission’s officer for public health research; and they 
met individual MEPS and as a group in the European Parliament.  
STEPS made a written response to the European Commission’s consultation 
on the future funding for research, and in May 2011, STEPS held in Brussels an 
Open Event with 60 participants, including a presentation by the Coordinator and 
responses from a panel including the European Commission (both DG Research - 
responsible for ERA, and DG Health – responsible for research liaison), a national 
research representative (Spain), and a CSO research representative (Slovakia). 
The event was reported in the media, and as a result of these actions
•  A call for social innovation was inserted into the programme for FP7 2012 
Health Research call; 
•  social innovation was identified as the topic for the European Commission at 
the Health Forum Gastein meeting in October 2011; 
•  social innovation was discussed with the EC Directorate for Health and Consumers 
for the new European Innovation Partnership for Active and Healthy Ageing; 
•  support for social and behavioural research in Horizon 2020 was also 
recommended at a consultation with researchers organised in July by the 
Directorate for Research.
As a Support Action, STEPS has sought to promote awareness of public health 
research with civil society and other stakeholders in the new member states, 
with ministries of health across the EU, and with researchers and the European 
Commission through EUPHA’s annual conferences. It has engaged with the 
development of research and health policy for both the EU and its member states 
for the forthcoming period in Europe. And for research, STEPS has produced 
academic papers putting knowledge of these issues in the science literature.
7.  Health 
Research -  
Europe’s 
Future
Response by STEPS and the European 
Public Health Association to the European 
Commission’s Consultation on the the 
Innovation Union.
April 2011
Health Research in Europe
The European Union and Member States’ 
responsibilities for health research are 
included in the Treaties of the European 
Union (Appendix 1). 
•  On public health, Article 168 says “Union 
action, which shall complement national policies, shall be directed towards 
improving public health, preventing physical and mental illness and diseases, and 
obviating sources of danger to physical and mental health”. 
•  For Research, Article 179 says “The Union shall have the objective of  
strengthening its scientific and technological bases by ... promoting all the 
research activities deemed necessary by virtue of other Chapters of the Treaties”.
[The Health Chapter of the European Union Treaty does not indicate research on 
treatment. Pharmaceuticals are only mentioned in terms setting ‘high standards of 
quality and safety’. ]
Europe’s Future
The EU Strategy for Growth (‘Europe 2020”) has three main headings, of which the 
first, ‘Smart Growth’, includes “research/innovation”.  And civil society is identified in 
implementing the strategy.
To promote the ‘Innovation Union’, European Innovation Partnerships are proposed. 
The first is a ‘Partnership for Active and Healthy Ageing, which has the aim of extending 
by two years by 2020 ‘the proportion of our lives in which we enjoy good health’
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Research for Health
EU activities for research are currently implemented by the European Commission’s 
Directorate for Research and Innovation, currently (2007-2013) through the Seventh 
Framework Programme (FP7). 
Member states all also have research programmes which combined considerably 
out-total the EU’s funds. However, they are rarely viewed together.
FP7 has four main groups of activities, entitled Cooperation, Ideas, People and 
Capacities. Cooperation has the most funding, with ten strands, of which Health 
holds the second largest budget, spending annually around €650m. 
The Health research Work Programme (Annex 2) is divided into four areas, which 
are described respectively: biotechnology, translational research, delivery of health 
care and other (cross-theme). 
In more detail, these headings may be re-presented as (1) biotechnology for 
pharmaceuticals, (2) biomedicine (laboratory and clinical sciences – should be 
noted here that the words ‘public health’ are used in the old-fashioned meaning of 
infectious diseases), (3) health care – this includes (3a)‘medicines, health therapies, 
technology’, (3b) healthcare quality & systems, and (3c) health promotion. (There 
has also been transferred (3d) international health, from elsewhere in 7FP, which is 
for programmes outside Europe).
Public health research is concerned with the fundamental Treaty responsibility for the 
health of the population. Yet in the Cooperation Programme, only two action lines for 
public health are supported (3b and 3c, for health systems and health promotion).  
And in annual programmes, only one of these is now ‘open’ (health promotion in 
2011, health systems in 2012)
In the 2011 Cooperation Health theme call, just €26 million of €650 million, 4%, 
was allocated to public health research for Europe. 
Member State health research systems
EUPHA (European Public Health Association) has contributed three studies of 
health research in Europe. 
•  SPHERE (Strengthening Public Health Research in Europe, FP6 Policy 
Programme, 2005-2007) undertook bibliometry of public health research fields 
and mapping of perspectives at European and national levels.
•  STEPS (Strengthening Engagement in Public Health Research, FP7 Science in 
Society programme, 2009-2011) has focused on civil society participation in health 
research the EU new member states (where the levels of health research are 
weakest), and mapped the structures of health research systems across Europe.
•  In PHIRE (Public Health Innovation and Research in Europe, DG Sanco Health 
Programme 2010-2012) EUPHA’s thematic Sections and member national 
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public health associations are assessing the uptake and impact of tracer health 
projects at ministry of health level, and comparing across EU countries.
Our findings are that public health research - heath systems, health promotion 
and health surveillance - has been less prioritised than biomedical research in EU 
member states, as well as the EU’s research progamme. 
Ministries of Science view public health research as a responsibility of the Ministries 
of Health, and yet few ministries of health have strategies or programmes for 
public health research. There is also a lack of support for applied social research in 
universities. Nor do Ministries of Health influence the development of the European 
Union’s health research agenda through their ministries of science or related 
research councils.
Moreover, the EU does not sufficiently cordinate Member States to address this 
issue. Member State Ministries of Health are rarely aware of each country’s health 
research programmes, and collaboration on public health research is weak.
The European Research Area for health will only be achieved when ministries 
of health and ministries of science coordinate their research, and focus 
towards the public health and health care research needs - a responsibility of 
the EU treaty that is not yet being sufficiently implemented.  
Achieving the Europe 2020 Health target
The EU Active and Healthy Ageing Innovation Partnership has set a target of two 
years lengthened life expectancy and quality of life. 
It has been demonstrated by studies by researchers in Europe and for the US 
Institute of Medicine that the improvement of life expectancy in past years has been 
mainly through public health measures. Treatment, despite the expenditure placed 
towards it, has provided less than 30% of the increase. (Appendix 3)
The impact in recent years is particularly on chronic diseases. But still the burden of 
chronic diseases (the ‘great scourges’) could be reduced by successful action in four 
areas – tobacco, diet, exercise and alcohol, while prevention interventions in other 
areas, particularly sexually transmitted diseases and accidents will also save many 
lives and disability. 
By contrast, further action to support pharmaceuticals, including so-called 
‘personalised’ medicines, and orphan drugs for rare diseases, will be give less health 
benfit and have higher costs.  
The improvement of life expectancy and ‘healthy ageing’ proposed by the EU 
will mainly be achieved by public health interventions for the whole population, 
much more than treatment in late stages of disease. 
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Innovation, private enterprise and technology 
The EU strategy ‘Europe 2020’ has identified seven priority themes, one of which is 
for an ‘Innovation Union’. The EU’s Directorate of Enterprise has interpreted this as 
implying more financial support for commercial industry and private enterprise.
While innovation can assist industry and commerce to be more economically 
competitive, it is equally important in public sector organisations. Europe’s 
economy is now more than 60% in the service sector, and the health system is a 
growing part of the services economy. 
Moreover, most technologies needed for better health and health care are ‘soft’ or 
‘social’ technologies for change – innovation in systems and services, in organisation 
amd management, policies and planning. Public health requires innovations 
in policies across the ‘wider determinants of health’ (food, tobacco, transport, 
sustainability etc), changes in health behaviours through cultural change, and 
changes within health services to achieve patient-centred and high quality care.  
In contrast to pharmaceuticals, public health research and development 
innovations that are needed will not be patentable or have IPR rights – yet they 
will have public good. This has been termed ‘market-failure’ research’ – in contrast 
to private market incentives which divert health research from primary prevention 
and systems research to pharmaceutical treatment of chronic disease (with no 
incentives for prevention).
EU Commissioner for Research Máire Geoghegan-Quinn said (Brussels, 17 
May 2011):‘Yes, social innovation can help us to meet new and unmet needs in 
society… That, in the end, is what the Innovation Union is all about.’ We ‘will set up 
a Social Platform … drawing up a European research agenda focusing on health, 
welfare and education services.’  
There must be less allocation of research funds towards ‘for-profit’ industry, 
and more to public investment in ‘market-failure’ research – health policy and 
health promotion, and health and welfare services organisation – to achieve 
greater effectiveness and value-for-money.
What should be done?
In organising the STEPS Open Event consultation on the Green Paper in Brussels, 3 
May 2011, EUPHA is calling on three groups of stakeholders
•  European Union institutions that set agendas for research
•  Member State ministries of science and health at national level, 
•  Civil Society Organisations representing citizens, researchers and practitioners
For the Innovation Union, the EU should serve its citizens by respecting its Treaty 
obligations for public health and to ensure research for health - health behaviour, health 
determinants and health systems - rather than prioritising biomedicine and bio-industry. 
The EU should 
create an 
integrated 
European 
strategy 
for health 
research and 
innovation, 
with 
appropriate 
expert 
advisory 
structure and 
high levels of 
funding
and give less 
emphasis to 
pharmaceutical, 
biomedical 
and biological 
research
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The EU should also develop necessary mechanisms of support for coordination and 
cooperation in public health research between member states.
National ministries of health need to work with ministries of science to agree health 
research priorities and strategies that meet the national health programmes and 
agendas. These will be across health system organisation, and health outcomes - 
impacts from prevention (including wider determinants) and clinical programmes. 
Civil society organisations can make an important contribution. They provide an input 
that is complementary to political forces, and they have interests primarily for society 
rather than commerce. EUPHA, as a professional organisation across the EU, is 
particularly interested in supporting the development of knowledge for best practice 
in public health, and achieving this in collaboration with member states and the EU.
We recommend that 
•  Not-for-profit research and innovation in medical and social disciplines is needed 
to deliver the ‘Health and Ageing’ target of longer disability-free life for Europe’s 
500 million citizens.
•  European member states should ensure dialogue and coordination between 
ministries of health and research ministries, to develop national health research 
priorities relevant to national public health policies and strategies.
•  The EU should create an integrated European strategy for health research and 
innovation, with appropriate expert advisory structure and high levels of funding, 
and give less emphasis to pharmaceutical, biomedical and biological research
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